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Electronic health record (EHR)-based computable phenotypes are algorithms used to 
identify individuals or populations with clinical conditions or events of interest within a clinical 
data repository. Due to a lack of EHR data standardization, computable phenotypes can be 
semantically ambiguous and difficult to share across institutions.  
In this research, I propose a new computable phenotyping methodological framework 
based on semantic web technologies, specifically ontologies, the Resource Description Framework 
(RDF) data format, triplestores, and Web Ontology Language (OWL) reasoning. My hypothesis is 
that storing and analyzing clinical data using these technologies can begin to address the critical 
issues of semantic ambiguity and lack of interoperability in the context of computable phenotyping. 
To test this hypothesis, I compared the performance of two variants of two computable 
phenotypes (for depression and rheumatoid arthritis, respectively). The first variant of each 
phenotype used a list of ICD-10-CM codes to define the condition; the second variant used ontology 
concepts from SNOMED and the Human Phenotype Ontology (HPO). After executing each variant of 
each phenotype against a clinical data repository, I compared the patients matched in each case to 
see where the different variants overlapped and diverged. Both the ontologies and the clinical data 
were stored in an RDF triplestore to allow me to assess the interoperability advantages of the RDF 
format for clinical data.
iv 
 
All tested methods successfully identified cohorts in the data store, with differing rates of 
overlap and divergence between variants. Depending on the phenotyping use case, SNOMED and 
HPO’s ability to more broadly define many conditions due to complex relationships between their 
concepts may be seen as an advantage or a disadvantage. I also found that RDF triplestores do 
indeed provide interoperability advantages, despite being far less commonly used in clinical data 
applications than relational databases. Despite the fact that these methods and technologies are not 
“one-size-fits-all,” the experimental results are encouraging enough for them to (1) be put into 
practice in combination with existing phenotyping methods or (2) be used on their own for 
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1.1 Problem Statement 
Phenotypes are sets of “observable traits above the molecular level,”1 and are used in the life 
sciences to define species and specific populations based on commonalities. Precise phenotyping of 
individuals is important in a number of areas. For example, in the field of genetics, genome-wide 
association studies (GWAS) compare genetic variants within phenotype-defined populations (e.g., 
“women with early-onset Alzheimer’s disease”) to determine if certain variants are associated with 
the given phenotype. GWAS requires precise phenotyping, as well as large numbers of cases and 
controls for adequate power.2 With the increased adoption of electronic health records (EHRs) after 
the HITECH Act of 2009, EHRs became a natural mechanism by which patients with precise 
phenotypes could be identified in larger numbers than could be individually recruited.3 Moreover, 
EHRs enable researchers to perform “reverse GWAS,” or PheWAS (phenome-wide association 
studies), where a range of clinical phenotypes is algorithmically determined for a particular 
genotype.4 Over time, as EHR-based computable phenotyping became an area of research in its own 
right, its utility quickly expanded beyond identifying populations for genetic studies to use cases in 
clinical research, clinical quality improvement, public health surveillance, and mandated reporting.  
EHR-based computable phenotypes (hereafter “computable phenotypes”) are algorithms 
used to query “data captured in the delivery of healthcare… to identify individuals or populations 
(i.e., cohorts) with conditions or events relevant to” some use case.5 An increasing number of 
clinical studies rely upon one or more computable phenotyping methods to define cohorts of 




from a number of inefficiencies and pitfalls. Phenotyping methods rely upon the data available in 
the EHR, which is imperfect; suffers from missingness, or the degree to which particular data 
elements are null or absent in data for a population; may not represent the “true” patient state; and 
can be semantically ambiguous.5 This is to some extent unavoidable, unless the practices used to 
collect and record EHR data in the clinic setting are drastically changed in the future. 
Due to a lack of EHR data standardization, computable phenotypes can be difficult to share 
across institutions, inhibiting collaboration opportunities and causing unnecessary rework to 
replicate findings.1,7 One of the major barriers to achieving robust, sharable, machine readable 
computable phenotypes is the way in which most healthcare institutions choose to structure and 
store their EHR data—in siloed, relational data warehouses, disconnected from other data sources 
and structured according to a custom or vendor-specific data model.  
In this research, I propose a new computable phenotyping methodological framework 
based on semantic web technologies, specifically the Resource Description Framework (RDF) data 
format, triplestores, linked open data, and Web Ontology Language (OWL) reasoning. My 
hypothesis is that storing and analyzing clinical and clinically relevant data using these technologies 
can begin to address the critical issues of semantic ambiguity and lack of interoperability in the 
context of computable phenotyping, and enable more collaborative, reproducible research using 
EHR data. 
1.2 Significance 
Due to the aforementioned pitfalls of EHRs, computable phenotyping generally entails 
running logic using imperfect codesets on imperfect data. If those imperfections are essentially 
inevitable in the current United States healthcare delivery paradigm, one might ask whether 
offering a new method of performing the same steps will really change much. The answer is 
(unsurprisingly) “it depends”—in this case, on the user of the phenotype, their aims, and their 




it is worth exploring why computable phenotyping has challenges with semantic ambiguity and 
interoperability in the first place, beyond the ways in which EHRs collect data—and why they are 
challenges worth solving.  
1.2.1 Semantic Ambiguity 
Computable phenotyping is highly dependent on structured EHR data. Structured data in 
the EHR context are data with a predictable data type and format which, as a result, are able to be 
efficiently queried. Examples of structured data elements include event date and timestamps, 
numeric lab results, and blood pressure readings. Many structured data elements rely on domain-
specific controlled vocabularies: LOINC (Logical Observation Identifiers Names and Codes) codes 
for lab tests and results, CPT (Current Procedural Terminology) codes for procedures, RxNorm for 
medications, ICD-10-CM (International Classification of Diseases, Tenth Revision, Clinical 
Modification) codes for diagnoses, and SNOMED CT codes for all of the above domains, among 
others. As the current study specifically uses diagnosis codes as a computable phenotyping test bed, 
additional detail about ICD-10 and SNOMED CT follow. 
1.2.1.1 ICD-10 
ICD-10 is a classification scheme for diseases and injuries that is used worldwide for 
epidemiology, statistical reporting of mortality and morbidity, and reimbursement purposes.8 As 
ICD-10-CM (the clinical modification; a subset of the entire ICD-10) is the standard coding scheme 
for diagnoses in the United States, ICD-10-CM codes are featured prominently in computable 
phenotypes. ICD-10-CM codes are between three and seven digits (alphanumeric characters), with 
the first three digits signifying the disease category, the fourth through sixth (optional) digits 
signifying etiology, anatomic site, or severity, and the seventh digit signifying the encounter (initial, 
subsequent, or sequela). Depending on the code, the seventh digit can be required, even if prior 




 The original International Classification of Diseases began with the work of the First 
International Statistical Congress at Brussels in 1853, despite a prevailing view that “a uniform list 
was impossible because of the different training of doctors and their tendency to call diseases by 
whatever name they chose.” Work on a standard continued in the decades following, though it 
would not see wide international adoption (as the International List of Causes of Death) until the 
1890s. In 1952, The US National Committee on Vital and Health Statistics began to study the 
possibility of using ICD not only for medical statistics, but for disease indexing in hospitals. As a 
result of this work, the US Public Health Service adapted the Seventh Revision of the ICD (ICD-7) 
with increased detail for use in hospital records. This practice of adapting the ICD with “clinical 
modifications” has continued to the present day, with ICD-10-CM serving as the standard diagnosis 
coding system in US health care institutions.10 
1.2.1.2 SNOMED CT 
The Systematized Nomenclature of Medicine (SNOMED) was published in 1975 as an 
extension to 1965’s Systematized Nomenclature of Pathology (SNOP). In contrast with ICD, 
SNOMED is not only concerned with disease, but also topography (anatomic sites affected by 
disease), morphology (structural changes associated with disease), etiology (cause of disease), and 
function (physiologic changes associated with disease). By 2000, SNOMED evolved into SNOMED 
Reference Terminology (RT), which used description logic to semantically define each concept. In 
2002, SNOMED RT was merged with the NHS Clinical Terms Version 3 to create SNOMED Clinical 
Terms (CT), which is still in use today. SNOMED CT is multilingual, comprehensive, large, and 
complex—so complex, in fact, that its concepts and relationships are not designed to be used 
manually, but rather by computers in an automated fashion.11 
 Unlike ICD-10-CM, SNOMED CT is not used for billing purposes in the US, and may thus be 
less familiar to US EHR users. SNOMED terms do exist in US EHRs in order to comply with 




patient problems, for example12—but these codes often exist behind the scenes, hidden from users 
as mappings in the EHR’s back-end database. As a global standard, however, SNOMED CT is an 
important tool for international clinical data exchange. 
1.2.1.3 A Case Study of Ambiguity 
With such well-established standards in place, it may be hard to imagine how those very 
standards contribute to semantic ambiguity. The fact that there can be more than one standard 
covering a single domain is certainly part of it, but there is more to it than that. As an example, 
consider a request to “identify all patients with a diagnosis of diabetes” in a clinical dataset. A 
Google search for ICD-10-CM codes for diabetes, which is where many investigators start their hunt 
for diagnosis codes, reveals that codes E08 through E13 signify diabetes mellitus.13 Querying 
SNOMED for diabetes mellitus (73211009) and its descendants, on the other hand, results in an 
indecipherable tangle of a graph (see Figure 1)—and when ICD-10-CM codes are mapped to that 
graph, the resulting set reveals many ICD-10-CM codes outside of the E08-E13 range. Appendix 1.1 
contains a listing of these codes. 
 
Figure 1. Graph showing the vast number of descendants of diabetes mellitus (node circled in 
green) in the SNOMED hierarchy. Red nodes are subclasses within SNOMED; blue nodes are ICD-10-
CM codes linked via the skos:closeMatch predicate used in this study (see Chapter 4). The full graph 






Looking closer at the SNOMED graph reveals that not that all of these codes are useful—in 
fact, many of them likely should not be used in a diabetes computable phenotype, as they are far too 
non-specific (e.g., though diarrhea can result of diabetes, “Diarrhea, unspecified” would match an 
enormous number of patients, only a few of whom may have diabetes). However, the list in 
Appendix 1.1 also reveals the ambiguity inherent in a request for “all patients with diabetes” in an 
EHR dataset. Does that request entail identifying patients with gestational diabetes, preexisting 
diabetes in pregnancy, or neonatal diabetes? Perhaps not, depending on the use case—but if those 
concepts should be included, they do not exist within the E08-E13 range, despite existing elsewhere 
in the ICD-10-CM terminology. 
It is important to remember that ICD-10-CM codes were never intended for the purpose of 
computable phenotyping. The ICD system was created for the purposes of medical statistics—
tracking mortality and disease within a population.14 In the US, however, ICD has become 
inextricable from the financial infrastructure of the country’s health care system, muddying its 
purpose. Among other issues, tying diagnostic coding with medical billing creates an incentive for 
“upcoding,” where diagnostic codes applied to a patient exaggerate the severity of their condition 
for the purpose of higher reimbursement.15 Moreover, ICD-10-CM codes are often applied to 
patients in order to justify the ordering of a test or procedure to insurers. Applying a code in this 
way does not necessarily entail that a patient has the disease—perhaps a test is being order to rule 
out a disease, or the patient is in remission from a disease. It is not hard to see how such practices 
could have significant downstream implications when ICD-10-CM codes are later used in 
computable phenotypes for cohort identification.   
Coming back to our diabetes example, we can now identify three different places where 
semantic ambiguity and subjectivity can distort reality. There is the meaning intended for the 




physician’s choice of code(s) to apply to the patient during the clinical encounter, and the way that 
the downstream researcher defines diabetes for the purpose of their clinical question. Figure 2 
illustrates how things can go awry when these three are not aligned.  
Figure 2. An illustration of the ambiguity of the definition of “diabetes.” 
 
*The official coding guidance from the Centers for Medicare and Medicaid Services (CMS) requires that a code 
in the O24 range be followed by an accompanying code in the E08-E13 range.16 However, an i2b2@UNC 
search executed on May 2, 2020 reveals that nearly 900 patients of UNC Health have an O24 code with no 
codes in the E08-E13 range, suggesting that the guidance is frequently not followed. These patients would be 
“missed” by a cohort search for codes in the E08-E13 range. This anomaly is likely not peculiar to UNC Health. 
 
 
What this illustrates is seemingly unavoidable semantic ambiguity. ICD codes are what we 
use to classify diseases in EHRs in the US, and that will likely be the case for the foreseeable future. 
Researchers and others have a need to identify cohorts in EHRs, and are generally forced to use 
ICD-10-CM codes to do so. But a code does not necessarily signify that a patient is a true positive 
case. Epidemiologist Major Greenwood identified this problem as far back as the 1940s, noting 
“Indeed, even trained statisticians sometimes confuse names with things. More than one rate of 
mortality has risen (or fallen) only on paper” (emphasis mine). Greenwood also recognized, 




who will wait for medical statistics until they are nosologically exact, is no wiser than Horace’s 
rustic waiting for the river to flow away.”17 
We also cannot take for granted that a researcher looking to identify a cohort will be an 
expert in each of their phenotype criteria. A researcher running a drug trial may need to exclude 
patients with certain types of cancer from the cohort, but is not herself a cancer researcher. 
Because of this, a researcher may not have a sophisticated understanding of all of the possible 
codes and variations for a condition in which they are non-expert. Asking such a researcher to 
provide the “right” codes in this circumstance is akin to asking them to order a restaurant meal 
without providing a menu. The key question, then, is what the ideal menu should look like. 
1.2.2 Interoperability 
Semantic ambiguity is highly related to interoperability, for interoperability cannot exist 
without shared meaning. However, clinical data interoperability goes beyond semantics. Benson 
and Grieve frame interoperability in the healthcare context as having four necessary components: 
 
 Technical interoperability, which ensures that data can be moved from one system to 
another; 
 Semantic interoperability, which allows the receiving computer to understand the meaning 
of the data as the sending computer intended; 
 Process interoperability, which allows the receiving human to share a common 
understanding of the data and its utility with the sender; and 
 Clinical interoperability, a subset of process interoperability, which requires a receiving 
clinician to use the exchanged data in a meaningful way during the course of clinical care.18 
 
As suggested in the title of Benson’s and Grieve’s chapter (“Why Interoperability is Hard”), 
healthcare institutions continually struggle to achieve true interoperability. There is no financial 




CM or CPT in the US), and many standards are intimidatingly complex. Additionally, the technology 
assets of healthcare organizations can be dense webs of legacy systems, one-off applications that 
serve a single purpose or group of users, “shadow” systems used alongside the official EHR for 
additional functionality, and other complexities that further impede interoperability. 
That is not to say that clinical data is not interoperable at all. The proliferation of Health 
Information Exchanges (HIEs), data-sharing networks that allow health care systems to 
automatically share their EHR data with other systems within and outside of their organization, is a 
testament to the fact that it is technically possible to share clinical data. NC HealthConnex, the North 
Carolina state HIE, has over 41,000 providers contributing data on over 6 million patients.19 This 
allows, for example, a patient who injures themselves on their beach vacation to have a subset of 
their clinical data from their provider at home sent automatically to their coastal emergency room.  
While this is certainly a step in the right direction, the interoperability offered by HIEs is 
smaller in scope than true interoperability. All HIEs are not created equal—though some are 
publicly funded, some are privately held, and others are vendor-specific (such as Epic’s Care 
Everywhere), leading to unevenness in capabilities and usability across HIE implementations. 
Moreover, some HIEs may only exchange the minimum amount of data to meet Meaningful Use 
requirements.20 With little financial incentive to do more than the minimum, potentially critical 
data points are left out of the exchange entirely. It bears repeating that interoperability, for all its 
benefits, is hard. 
1.3 Aims of This Work 
The issues of semantic ambiguity and lack of interoperability in clinical data are too vast in 
scope to have a single solution. A starting point, however, is to look at smaller, more confined use 
cases within the world of clinical data that could serve as a test bed for experimentation. One such 




semantic and technical interoperability. EHR data-driven research has a number of characteristics 
that make it an ideal test case for the present work, including: 
1. A focus on cohorts of patients defined by a computable phenotype, rather than all the 
patients in the EHR. 
2. A focus on one or more specific disease states or conditions, rather than any possible 
human health condition. 
3. A focus on a defined list of variables of interest, rather than every scrap of information 
recorded in the EHR.  
4. An increasing need for interoperability (for multi-site studies as well as reproducibility).  
 
EHR data-driven research thus presents a more manageable scope for experimentation. 
Considering these benefits, in this study, I chose to focus my efforts on improving semantic 
ambiguity and interoperability this research context. The findings and lessons learned should, I 
believe, translate to EHRs and clinical data as a whole, if only as one part of a larger solution. 
 The chapters that follow use computable phenotyping in the context of EHR data-driven 
research as a framework to answer the following research questions. 
 
Research Question 1: Can clinical ontologies (specifically SNOMED CT and the Human 
Phenotype Ontology) offer a less semantically ambiguous mechanism to perform computable 
phenotyping than reimbursement-focused terminologies (specifically ICD-10-CM)? 
 
Research Question 2: Does the use of semantic web technologies and standards (e.g., Resource 
Description Framework (RDF), triplestores, the Web Ontology Language) in tandem with 




To answer RQ1, I devised an experiment whereby the performance of validated, ICD-10-CM-
based computable phenotypes (for depression and rheumatoid arthritis, respectively) can be 




(By “performance,” here I am referring to a computable phenotype’s ability to identify patients 
qualifying for its criteria within a clinical data repository.) The experiment was conducted using 
EHR data residing in an existing RDF triplestore (“the Opioid Triplestore”) built as part of prior 
research work, described in Chapter 3.  
Because ontologies are a natural fit for semantic web technologies (as detailed in Chapter 
2), a triplestore was the logical choice to store and query both the ontologies themselves and the 
underlying clinical data, and would also serve to answer RQ2. However, as the Opioid Triplestore 
used to execute the experiment for RQ1 was built before the current work began, it was not 
specifically built with interoperability in mind. Thus, to fully answer RQ2 I constructed an open-
source data processing pipeline to take clinical data from its native, relational format to RDF and 
OWL. This pipeline is capable of constructing the Opioid Triplestore (and any other clinical 
triplestore) from scratch—but unlike the existing repository, is fully documented, sharable, and 
extensible.  
Chapter 2 presents a review of the literature surrounding standard clinical data models, use 
of non-relational database technologies to store and analyze clinical data, and the prevailing 
methods of computable phenotyping. Chapter 4 describes the methods and software used in my 
experiment and pipeline construction, and Chapter 5 details the results of that work. Chapter 6 
applies these findings to the research questions and discusses the findings’ implications and 
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II. LITERATURE REVIEW 
2.1 Introduction 
A user’s ability to make use of computable phenotyping relies on three major components: 
 
1. The user’s ability to compose accurate, comprehensive computable phenotype logic; 
2. The user’s understanding of underlying clinical data models, terminologies, and ontologies; 
and 
3. The availability of database technologies appropriate for the scope and scale of the user’s 
desired analysis. 
 
Each of these components have been the subject of significant study.  This chapter summarizes this 
prior research, which greatly informs the experimental aims of this work. 
In the context of this review, clinical data are data about a human patient collected in a 
healthcare setting or under the direction of a healthcare provider, with an aim of tracking that 
patient’s health status. This might include vital sign measurements, laboratory results, progress 
notes, and imaging studies, among many other possibilities. Clinically relevant data are data that are 
not collected directly from or about a given patient, but can be linked to a patient’s clinical data to 
provide a richer picture of that patient’s health. Examples include metadata about gene variants 
that can be linked to a patient’s genomic testing results or air pollution data that can be linked to 




2.2 Computable Phenotyping 
2.2.1 Current State of the Field 
Computable phenotypes are algorithms used to query “data captured in the delivery of 
healthcare… to identify individuals or populations (i.e., cohorts) with conditions or events relevant 
to” some use case.1 An increasing number of clinical studies rely upon one or more computable 
phenotyping methods to define cohorts of interest.2 There are several categories of computable 
phenotyping methods currently in use in the field of clinical informatics: rule-based, natural 
language processing-based, machine learning-based, and hybrid, mixed-method models:2 
 
 Rule-based: defining phenotypes using logical constraints against structured data (e.g., 
“men over age 65 with at least one HbA1c value greater than 8.0% in the last two years”) 
 Natural language processing: analyzing free-text sources such as clinical notes to infer 
phenotypes that cannot be obtained from structured data 
 Machine learning and statistical analysis: using machine learning and statistical models 
against EHR data to learn patterns indicative of phenotypes  
 Hybrid approaches using the above methods2 
 
Though the current study focuses on rule-based computable phenotyping, the other three methods 
continue to gain prominence as the skillsets required to execute them become more common. 
In the years since 2009’s HITECH Act, which incentivized the implementation of EHRs 
across the US healthcare system, computable phenotyping has become the standard mechanism to 
identify large patient cohorts. However, as mentioned in Chapter 1, computable phenotyping 
suffers from a number of inefficiencies and pitfalls. Each of the computable phenotyping methods 
listed above rely upon the data available in the EHR, which is imperfect, suffers from missingness, 
may not represent the “true” patient state, and can be semantically ambiguous.1 Moreover, due to a 




inhibiting collaboration opportunities and causing unnecessary rework to replicate findings.3,4 One 
of the major barriers to achieving robust, sharable, machine readable computable phenotypes is the 
way in which most healthcare institutions choose to structure and store their EHR data—in siloed, 
relational data warehouses, disconnected from other data sources and structured according to a 
custom or vendor-specific data model.  
The ideal computable phenotype is shareable, data model agnostic, semantically 
unambiguous, machine readable, and publicly accessible. This has not yet been achieved at scale, 
but some version of this ideal has been advocated by many.1,3,5–8 More specifically, Deans et al. 
suggest that the lack of infrastructure to support this ideal is “perhaps the most pressing scientific 
bottleneck to integration across many key fields in biology.”3  
The use cases for computable phenotyping are vast and varied. In addition to 
straightforward cohort identification for research studies, quality improvement, and mandated 
reporting requirements, computable phenotyping also has the capacity to help make new 
discoveries. As noted in Chapter 1, GWAS compares genetic variants within phenotype-defined 
populations to determine if certain variants are associated with the given phenotype. In the last 
decade, researchers have explored the concept of GWAS in reverse, or PheWAS (phenome-wide 
association studies), which are directly enabled by computable phenotyping against EHR data. By 
running a computable phenotype against the entire population in an EHR (which is, for the most 
part, disease agnostic in a large healthcare system), and then linking patients in the identified 
cohort to available genetic information (from, for example, biobanks), it is possible to both 
reproduce and validate previously known gene-disease associations, as well as discover new 
associations.9–11  
2.2.2 The Process of Computable Phenotyping 
Using any computable phenotyping method has some prerequisites: a question (i.e., a 




algorithm variables (such as diagnosis, procedure, or medication codes).12 These algorithm 
variables are most often accompanied by various logical constructs to further refine the phenotype 
definition (e.g., laboratory result x occurs within y days of event z; patient has at least x encounters 
in the last y years; diagnosis x must be asserted by a physician with specialty y, etc.). Rasmussen et 
al. refer to these and other common constructs as “design patterns” that tend to occur again and 
again across phenotype definitions.13 
The process of executing a computable phenotype is also generalizable. This process can be 
summarized as follows, with each step requiring one or more rounds of iteration for testing and 
revision: 
 
 Exploration: Domain experts are consulted to draft a list of codes and/or characteristics 
that may indicate the chosen phenotype. Manual chart review or test queries (e.g., to 
determine whether the chosen codes are actually used in clinical practice) may be used to 
refine the draft list.  
 Algorithm definition: Based on the results of the exploration step, a set of rules is created 
to execute against the EHR data to identify the population of interest. At this stage, these 
rules may be presented as pseudo-code or a flow diagram. (See Figure 1 for an example of a 
phenotyping flow diagram.) 
 Algorithm implementation: Rules are translated to executable code. 
 Validation: Domain experts manually review a subset of identified patients to determine 





Figure 1. Flow diagram for a computable phenotype to identify patients with cataracts, publicly 
available on PheKB.org.15 
 
This generalized process may differ based on the method chosen—for example, algorithm 
definition may be unnecessary for machine-learning based phenotypes, which “learn” rules based 
on the data.16 Semi-supervised or unsupervised machine learning may also allow for a less refined 
exploration step, or render it unnecessary.17,18 
The phenotype development process is necessarily interdisciplinary in nature, at the very 
least involving a domain expert (such as a clinician) to define the phenotype and an informatician to 
translate that definition into code. Inexactitude and errors can be introduced at this critical step if 




motivation behind the development of various user-friendly phenotyping software tools intended 
to be used by domain experts (supposedly cutting out the informatician)—however, these tools’ 
lack of computational sophistication makes them difficult or impossible to use in order to execute 
more complex phenotypes.19  
There are many caveats to consider when using EHR data to define populations. The most 
essential point is that “the EHR is not a direct reflection of the patient and physiology, but a 
reflection of the recording process inherent in healthcare with noise and feedback loops.”20 As such, 
important data can be missing or inaccurately recorded, the data may not reflect the full complexity 
of a patient’s condition, and the data may be biased toward high utilizers (i.e., sicker patients will 
generate more data).6,19,20 Moreover, the context in which EHR data is collected, which can either be 
clinical or administrative, has a major impact on the meaning of the collected data.1,14 As an 
example, a diagnosis code for diabetes can be applied to patients who have diabetes (clinical 
context), or may be used by a physician to justify the ordering of a lab test to test for diabetes in a 
patient who may or may not have the disease (administrative context). The diagnosis code used 
would be the same in either case, but context leads to two very different meanings. In such cases, 
neglecting to annotate concepts with their context in the phenotyping process (a type of semantic 
ambiguity) can lead to misidentified patients. 
Considering these caveats, expert validation is an essential step in any computable 
phenotyping effort. As with phenotype development, validation is generally an iterative, 
interdisciplinary process involving informaticians, biostatisticians, and domain experts such as 
clinicians, epidemiologists, or geneticists manually reviewing the population identified by the 
computable phenotype.6,12,19,21 Richesson et al. advocate for two types of validation: face validity 
(determining whether the phenotype definition has been faithfully translated to code) and 
discriminant ability (determining whether the computable phenotype accurately identifies the 




2.2.3 Sharing Computable Phenotypes 
Though a computable phenotype may be validated within the bounds of a single healthcare 
institution, there are still many barriers to sharing that phenotype with other institutions. Different 
institutions may use different EHR systems and/or data definitions, limiting portability of the code 
used to define the computable phenotype. At a minimum, use of standard terminologies such as 
ICD-9/-10 (diagnoses and procedures), LOINC (laboratory measures), RxNorm (medications), or 
SNOMED CT (clinical concepts) can aid in portability, though an individual institution’s use of such 
terminologies is not guaranteed, and some mapping effort may be required.1,2,5,6,21 A more robust 
solution is the use of one of the major common data models (CDM) across institutions, such as i2b2, 
OMOP, or PCORnet (described in more detail in 2.3.1.3) which enforce common data structures and 
definitions, and thus enable code portability. However, as implementing CDMs requires significant 
institutional effort, this is not a universal solution.  
Another phenotype sharing solution was developed by the Electronic Medical Records and 
Genomics (eMERGE) network, a consortium of institutions funded by the National Human Genome 
Research Institute to combine DNA biorepositories with EHR data. To support their work, eMERGE 
devised a phenotype sharing portal known as the Phenotype Knowledgebase (PheKB, available at 
http://phekb.org), where organizations are encouraged to share validated computable phenotypes 
with enough detailed documentation to allow other institutions to locally replicate the phenotype 
logic.22 PheKB is highly regarded; however, because the phenotypes posted to PheKB are human-
readable descriptive documentation rather than computer-readable code, institutions wishing to 
implement a PheKB phenotype are required to “translate” the PheKB documentation into logic and 
code that will work locally. For a complex phenotype, this effort may be significant—and, as 
mentioned earlier, inexactitude and errors can be introduced in this translation step. In order to 




phenotype logic toward more stringent clinical data models and machine-readable phenotype 
rulesets.  
2.3 Clinical Data Models, Terminologies, and Ontologies 
2.3.1 Standard Clinical Data Models 
The benefits of healthcare data interoperability are clear, both intra- and internationally. 
The ability to cross-query and combine data from multiple healthcare organizations is essential 
across a spectrum of use cases, from ensuring that a single patient’s records can be easily 
transmitted from clinic to clinic, to running population-level analytic queries encompassing tens of 
millions of patient records. In order to ensure this level of interoperability, it is necessary for data 
providers to agree to use a CDM, where data are stored in an agreed-upon, identical structure, and a 
given data element has the same semantic meaning across all implementations.  In practice, many 
healthcare organizations do not use a CDM, and instead use a locally defined data model that meets 
the needs of their organization. Though a universal clinical data model is currently more an ideal 
than a reality, the importance of improving interoperability makes it well worth pushing 
organizations in this direction.  
There are several existing “generic” healthcare data models in use in the US and 
internationally, each of which is built with flexibility in mind, as the speed with which healthcare 
data collection and analysis needs change would render a rigid data model outdated very quickly. A 
selection of these data models are briefly defined here. 
2.3.1.1 openEHR 
openEHR is a multi-level data model. At the bottom, a stable “reference model” (RM) 
contains highly generic “building blocks,” or data structures (e.g., the concept of a DATA_VALUE) 
that can be used by higher-level classes. More specific domain concepts are expressed in higher 




model a given domain concept.  (E.g., a blood pressure is a concept made up of two numeric data 
values with the meanings “systolic blood pressure” and “diastolic blood pressure,” respectively.) 
Adding a new archetype simply requires combining and defining the right RM building blocks (and 
does not require any changes at the RM level or its persistence mechanism), which makes openEHR 
highly adaptable to changing data needs.23 openEHR architecture is widely used to structure EHR 
data in the United Kingdom, Australia, Brazil, and others; it appears to be far less common in the 
US.24  
2.3.1.2 HL7 
Health Level 7 (HL7) is a health data standard focused on enabling standardized exchange 
of electronic health record (EHR) data among healthcare providers. HL7 exchanges data as 
“messages,” triggered by events in the healthcare setting (such as the return of a lab result). HL7 
messages are constructed from building blocks contained in the HL7 Reference Information Model 
(RIM). The RIM provides classes, attributes, and connections needed to construct all HL7 message 
types.25 There are many “flavors” of HL7 standards; four of the most widely used are summarized 
below.  
 
HL7 versions 2 and 3. HL7 v2, released in 1987, and HL7 v3, released in 2014, are widely 
implemented messaging standards to enable healthcare data exchange. HL7 v2 is used by 95% of 
US healthcare organizations and in more than 35 countries.26,27 Use of HL7 v3 is less common. 
 
HL7 CDA. HL7 Clinical Document Architecture (CDA) encodes the structure and meaning of clinical 
documents so that those documents can be exchanged seamlessly with other healthcare systems. 
The difference between a document and an HL7 v2 or v3 message is that documents “have 
persistence, wholeness, and clinician authentication and are human readable,” while messages are 




patient data from organization to organization via health information exchanges, as described in 
Chapter 1.  
 
HL7 FHIR. Beginning in 2011, HL7 recognized that v3 had not achieved the expected level of 
uptake, and began to focus its attention on creating a new standard: Fast Healthcare 
Interoperability Resources (FHIR).29 FHIR combines aspects of HL7 v2, v3, and CDA into a new 
standard with a focus on ease of implementation. FHIR’s building blocks are “resources,” like 
Patient or Encounter. Individual users can adapt resources to their needs by combining them into 
“profiles,” which can be further customized with “extensions” to make use of data not covered in the 
standard FHIR resources.30 Though its first version was released in 2012, FHIR is still an emerging 
standard—however, its current level of uptake is a promising sign that it will eventually be very 
widely used.31 
2.3.1.3 OMOP, PCORnet, and i2b2 
The three major clinical CDMs in use by the academic research community are i2b2 (in 
tandem with the ACT ontology),32,33 PCORnet,34 and OMOP,35 each of which uses a slightly different 
architecture to achieve the same end: to represent and store EHR data in a relational database. The 
ability to query common data structures and provision data to collaborators in a shared format 
reduces the burden on data analysts and enforces common definitions that allow clinical data to be 
appropriately merged and compared across institutions. These data models are not designed to 
hold any and all healthcare data elements, and due to their emphasis on standardization, are 
actually somewhat limited in terms of flexibility. Rather, they emphasize community agreement on 
the essential EHR data elements to capture, and ensure that those data elements can be completely 
standardized in the data model for seamless interoperability across sites.  
Unlike openEHR and HL7, these data models are not used or loaded natively by EHRs, and 




EHR data. For this reason, these models are much more likely to be used by academic medical 
centers or large healthcare institutions with information technology resources than by a 
community hospital or small clinic.  
Without the use of common code sets, even data structured in a CDM would not be 
interoperable. Thus, the benefits of CDMs cannot be considered in full without also discussing the 
terminologies and ontologies used within. 
2.3.2 Healthcare Ontologies and Terminologies 
An ontology is a systematic representation of knowledge; a way to consistently classify and 
define data across users, databases, institutions, and even countries. Terminologies are controlled 
vocabularies in a given domain, such as ICD (the International Statistical Classification of Diseases 
and Related Health Problems) for diagnoses and procedures, or LOINC (Logical Observation 
Identifiers Names and Codes) for laboratory tests and results. Ontologies and terminologies provide 
common terms and definitions for, in this case, clinical concepts. Ontologies also allow for 
computational logical reasoning on the relationships between concepts, which is not the case with 
terminologies.36 Both ontologies and terminologies are used extensively by many data-driven 
clinical studies, enabling not only interoperability (and perhaps reproducibility), but in the case of 
ontologies, also the potential to increase dataset richness with new logical assertions. As data get 
larger in volume and more heterogeneous, use of ontologies and terminologies to label data will 
becoming increasingly important to ascribe valid, consistent meaning to data points across 
disparate sources. 
 As this work focuses primarily on ICD-10-CM and SNOMED CT, it is worth delving deeper 
into their identities as a terminology and an ontology, respectively. As noted earlier, ICD is a 
terminology, not an ontology. Stenzhorn, et al. explain the difference with an example, noting that 
ICD makes frequent use of “not specified” (e.g., ICD-10-CM code M19.90, “Unspecified osteoarthritis, 




classification. This is a very practical consideration—despite not having all the information, the 
patient’s condition must be documented to the best of the coder’s ability. However, the concept of 
“not otherwise specified” does not fit within an ontology, which is concerned about documenting 
what is rather than contextual knowledge.37 The difference may seem minor, but it has wide-
ranging implications for the utility of ontologies in clinical practice. There is a clinical and 
administrative need to document contextual knowledge, particularly in the realm of diagnoses (and 
because ICD is used for reimbursement)—meaning that ontologies alone cannot meet all clinical 
classification needs. Rather, both ontologies and terminologies have their place. 
 On the other hand, SNOMED CT is referred to alternatively as a terminology and an 
ontology. Rodrigues et al. suggest that SNOMED CT can appropriately be considered an ontology 
due to its use of compositional grammar and description logic.38 The International Health 
Terminology Standards Development Organization (IHTSDO), the current owners of SNOMED CT, 
define compositional grammar as “the set of rules that govern the way in which SNOMED CT 
expressions are represented as a plain text string.”39 A simple expression could be as short as a 
single concept (e.g., 69896004, the SNOMED code for rheumatoid arthritis). However, SNOMED’s 
compositional grammar also allows for much more complex expressions, as in the example below: 
71388002 |Procedure| : 
405815000 |Procedure device| = 122456005 |Laser device| , 
260686004 |Method| = 129304002 |Excision – action| , 
405813007 |Procedure site – direct| = 15497006 |Ovarian structure| 
This expression equates to “the removal of an ovarian structure using a laser device.” (Example 
adapted from IHTSDO’s SNOMED CT Compositional Grammar Specification and Guide.39) 
“Description logic” is a logic-based formalism to represent characteristics of concepts. By 
encoding which concepts are sub- or supertypes of other concepts (e.g., “infectious disease” is a 
supertype of “bacterial infectious disease”; “bacterial infectious disease” inherits all characteristics 
of “infectious disease,” with additions), description logic allows SNOMED CT concepts to be 




For the purposes of this study, we will consider SNOMED CT an ontology. 
2.4 Database Technologies for Use with Clinical Data 
A database or data warehouse is a prerequisite in order to execute a computable phenotype 
or implement a clinical data model. More than just an afterthought, the technical infrastructure 
deployed for use with clinical data has a direct effect on phenotype complexity and cohort size. As 
clinical data gets larger over time, this consideration only becomes more important. I settled on the 
RDF triplestore as the non-relational technology to use in this research, this choice was made only 
after surveying the full landscape of non-relational models for the best fit. Thus, the review below 
touches not only on triplestores (see 2.4.3.4), but on alternative relational technologies that led me 
to my final choice. 
2.4.1 Clinical Data as Big Data 
Big data is gaining prominence in many fields of analytics; healthcare is no exception. Vast 
quantities of data are collected during patient encounters with healthcare systems, even when the 
data’s future use may be unclear. Though relational database management systems (RDBMS) and, 
likewise, the relational data model are in use by the vast majority of healthcare delivery systems for 
data storage and analysis, non-relational (NoSQL, or “not only SQL”) technologies are becoming an 
increasingly attractive option in the healthcare domain. 
Big data is often discussed as having a combination of four characteristics of data (the “four 
Vs”): high volume, wide variety, high velocity, and varying veracity. Though there is nothing 
preventing the relational model from being used to store and analyze data with these 
characteristics, NoSQL technologies are particularly well-suited to scaling (due to their ability to be 
distributed across many compute nodes) and adeptly handling dynamic and changing data 
models.41  
The worldwide volume of clinical data is expected to reach 25,000 petabytes in 2020.42 




data is often gathered at high velocity, such as readings from a sensor. And, as the field of medicine 
is far from settled, and new information is continuously being discovered, clinical data is also of 
changing veracity. Thus, depending on the use case, clinical data has the potential to be big data, and 
a NoSQL solution may be as or more appropriate than an RDBMS for storage and analysis.  
NoSQL technologies are gaining prominence in industry and research, but are relatively 
new in the healthcare domain. NoSQL databases have potential to outclass RDBMS in terms of 
query performance; modeling dynamic, heterogeneous data; integrating semantics and reasoning 
capabilities; and modeling highly related data. Considering the increasing volume of clinical data 
and the increasing complexity of healthcare analytics, a review of the literature surrounding the use 
of NoSQL technologies in the healthcare domain is in order to summarize the current state of the 
field and set the agenda for future study. 
2.4.2 Distinctions between Relational and NoSQL Databases 
Relational databases are databases that rely on the relational model created by E.F. Codd in 
1970.43 Relational databases support ACID (Atomicity, Consistency, Isolation, Durability) 
transactions in order to guarantee data validity. As an example, these rules prevent two 
transactions from updating the same data at the same time (possibly to different values). However, 
enforcing ACID properties in a distributed computing environment is much more challenging; as 
such, many NoSQL technologies (which are often distributed) enforce BASE: Basically Available, 
Soft State, Eventually Consistent. In the BASE model, data are eventually valid across nodes, but 
validity is not guaranteed at all times. (Moreover, NoSQL databases generally do not support 
integrity constraints, which are frequently used as data quality checks.) In addition, distributed 
NoSQL databases are subject to the CAP theorem, which states that a networked database can have 





NoSQL databases can be grouped into four distinct types: key value, document, column, and 
graph. Each type is well-suited to a particular use case, and may be poorly suited for others.   
2.4.3 Reviewing NoSQL Technologies for Use with Clinical Data 
2.4.3.1 Key-Value Stores 
A key-value store is a highly simplified data storage mechanism, emphasizing performance 
over data organization. In a key-value store, each piece of data (or value) is identified and stored as 
a pair with a unique key in simple tables known as hash tables. Values can be of any datatype 
(requiring no upfront modeling), but queries can only be run as exact matches against keys (i.e., one 
cannot filter results based on values), and only CRUD (Create, Read, Update, Delete) operations are 
supported.44 Redis and Riak are examples of popular key-value stores. Prior studies that made use 
of key-value stores with clinical data are summarized in Appendix 2.1. 
Schemalessness is often cited as a reason to use key-value stores for health care data.45–47 
Mazurek suggests that this characteristic of NoSQL justifies doing away with lengthy Extract-
Transform-Load (ETL) procedures, which are used to structure and populate data in relational 
databases—rather, data can be loaded “as is” into key-value stores.48  
Panahiazar, et al. presented a unique affordance of their key-value store: efficient semantic 
annotation of semi-structured and unstructured data using Hadoop’s MapReduce framework over 
multiple nodes. Using this setup, an annotation job that was estimated to take 40 days was reduced 
to approximately 2 days.46 However, Lee, et al. note a disadvantage of key-value stores when 
modeling unstructured data—the potential for enormous numbers of rows (i.e., key-value pairs) to 
be generated to represent the contents of a clinical note. Even still, the key-value store 
outperformed an XML database in their experiment, suggesting that an extremely high row count is 
not necessarily problematic from an efficiency standpoint.47  
Klein, et al. found that the key-value store used in their experiment (Riak) did not perform 




relationships (such as patient to lab results) and “most recent” observations was more complex and 
less efficient in the key-value store.49 Chrimes, et al. noted that while performance for both simple 
and complex queries was impressive (< 4 seconds for all queries over 3 billion records), getting the 
data prepared for use in HBase took months of work.45 This amount of effort may simply be 
indicative of the fact that non-relational data structures are new to the health care space, but may 
also reflect that much more work is needed to streamline start-up tasks. 
2.4.3.2 Column Stores 
Column stores store each database column separately and highly compressed, with column 
entries rather than row entries stored in contiguous memory locations for easy retrieval. When 
querying, without the need to read in potentially unnecessary columns, reads have the potential to 
be much faster than a relational database. Additional read efficiency is gained because columns, 
which contain data of the same type (and similar domain, presumably), can be compressed more 
densely than rows, which can contain heterogeneous data. As writes are far less efficient in a 
column store, column stores are best suited for read-intensive applications.50 Apache Cassandra, 
Apache HBase, and Google BigTable are all examples of column stores. Prior studies that made use 
of column stores for clinical data are summarized in Appendix 2.2. Reasons to choose a column 
store over other non-relational technologies are varied, and include quick reads,45,49,51–54 
conduciveness to distributed architecture,49,51,54 and flexible schema.52  
Apache Cassandra has proven to have very good query performance in a number of studies, 
though Celesti et al. noted that the performance improvement over a relational database was 
actually not significant in their experiment unless Cassandra was deployed in a distributed manner; 
Klein, et al. echoed that implementing Cassandra in a distributed configuration resulted in better 
performance.49,51  Zeng, et al. discovered that Cassandra’s query performance was significantly 
faster than MySQL, but performed similarly to MySQL when loading and harmonizing data.53 




column store (Apache HBase), suggesting that, regardless of performance, column stores are in fact 
suitable for clinical data use cases.52 
2.4.3.3 Document Stores & XML Databases 
Document-oriented databases, or document stores, use “documents” rather than tables as 
their data storage mechanism. A document is a collection of semi-structured data encoded in a 
standard format like JSON or XML. (Document stores that store documents encoded in XML are also 
referred to as “XML databases.”) Document stores offer very flexible schemas and are highly 
denormalized, and therefore may not be appropriate for use with highly related data.55 Unlike a 
key-value store, a document is considered as a whole rather than split into key-value pairs. 
Indexing, however, allows a user to query on document identifiers and properties.42 Where data is 
text-heavy and heterogeneous in structure, the flexibility of a document store can be advantageous. 
MongoDB and Couchbase are examples of document stores. Prior studies that made use of 
document stores and/or XML databases for clinical data are summarized in Appendix 2.3. 
Among these studies, documents are seen as a more “natural” way to store EHR data, which 
is often semi-structured or in free-text,23,47,56 and more specifically, are seen as a better format to 
allow users to query directly against free-text.57,58 Freire, et al. note that archetype-based clinical 
data models (like openEHR) are tree-structured, which is mismatched in structure with the 
relational model. Workarounds are required in order to model a tree-structured hierarchy in a 
relational database (and querying such a structure can require many joins), which comes at a 
performance and efficiency cost.23 Storing data in JSON (or XML, or other similar formats) may be 
better able to represent hierarchical data. 
The most appropriate database for a health care application depends on the data’s primary 
use, and what kinds of queries are mostly likely to be issued. Gabetta, et al. demonstrated this 
principle in their unique hybrid approach, where genomic data is stored as documents (one JSON 




relational i2b2 data model.59 Another good fit for a document store is retrieving a wide variety of 
data for a single patient (much like pulling up a patient’s chart in the EHR), as a single patient’s 
chart is a document, and can thus be efficiently retrieved. Use cases that require joins between 
documents, however, may be better served by a relational database.60  
Several studies specifically mentioned document stores’ schemalessness as a distinct 
advantage,42,57,59,61,62 as the types of clinical data collected (and needed for querying and reporting) 
is constantly changing. Whereas it can be difficult to change the structure of a relational database to 
accommodate new or charging requirements, a document store can easily ingest documents with 
new data elements added.  
Three studies that specifically used an XML database found the XML database to be 
relatively non-performant in terms of query execution time, especially when compared with non-
XML document stores (like Couchbase and MongoDB), as well as relational databases.23,47,60 Outside 
of these XML databases, document stores generally performed as well or better than relational 
databases for their chosen use cases when benchmarked.  
2.4.3.4 Graph Databases 
Graph databases, which store data as a network of nodes and edges, are an appealing NoSQL 
option when the relationships between data are as important as the data itself.63 There are two 
types of graph databases, which are different enough to justify splitting studies using graph 
databases into two categories: triplestores and labelled property graphs. 
 
Triplestores. A triplestore is the storage mechanism for data formatted in Resource Description 
Framework, or RDF. RDF is a W3C standard for data exchange on the web, represents data as a 
graph, and is heavily connected with the concept of the “semantic web.” Triplestores store data as 
triples, or statements in the format subject – predicate – object. (E.g., Michael Strauss (subject) is a 




simplicity, as a wide variety of information can be encoded as triples. The rigidity of the triple 
format, however, is what allows the data contained in triples to be understood and consumed by 
different agents across the web. Moreover, many widely used, publicly available ontologies are 
written in the web ontology language, OWL, which can be natively stored and used in a triplestore. 
This makes triplestores a popular choice for those applications looking to leverage ontology-based 
querying and to incorporate external sources of data. AllegroGraph and Blazegraph are examples of 
triplestores. Prior studies that made use of triplestores for clinical data are summarized in 
Appendix 2.4. 
Though ontologies don’t require use of a triplestore, ontologies written in the OWL 
language are easily consumable by triplestores, and are thus a natural fit. Fernandez-Breis, et al. 
note that ontologies allow users to work with information at both the “data level” and the 
“knowledge level,” as relationships between concepts in an ontology allow the user to make new 
logical inferences that are not specifically recorded in the data.64 “OWL reasoning,” another 
capability afforded by RDF, is an extension of this knowledge level, in that new assertions can be 
concluded in an automated fashion based on existing assertions in the triplestore.65–67  
Use of standard ontologies (such as SNOMED) also promotes interoperability, even without 
using a standard clinical data model (HL7, openEHR, etc.). This may be an especially useful feature 
for cancer registries, rare disease registries, and EHR data spread across multiple institutions, 
states, or countries, which, rather than being siloed, can be joined together using common 
semantics, as well as joined with external data sources for richer querying.68–73 External data 
sources may include one or more of the datasets available on the web as Linked Open Data, or LOD, 
an open data repository expressed in triples. Many of the datasets available as LOD are biomedical 
in nature, and could allow one to link EHR data with public data to discover, for example, gene-
disease associations, genotype-phenotype associations, or drug-drug interactions.74–77 Free-text 




can also be transformed into triples and linked with standard ontologies to enable 
interoperability.76,78,79 As with the other non-relational models, several studies cited triplestores’ 
ability to combine heterogeneous data in a single repository as an important factor.  
RDF operates under the “open world assumption,” which states that the absence of an 
assertion in a triplestore does not mean that that assertion is false. Kilintzis, et al. note that this 
feature of RDF may be at odds with the exactitude of (some) clinical data.80 However, leveraging 
semantics also promotes exactitude by ensuring that data are semantically unambiguous—that is, 
whether a data point is used for clinical care, a research study, or population-level analytics, its 
meaning will remain consistent and well-documented.73,81 
 
Labelled Property Graphs. Compared to triplestores, labelled property graphs (LPGs) are more 
focused on data persistence and querying rather than data exchange. LPGs are not locked in to the 
triple format, and are adept at executing queries that traverse a graph, hopping from one node to 
the next until the desired result is reached. Nodes and edges in an LPG can be annotated with 
additional information that does not easily fit in the RDF model, such as data provenance. Neo4j is 
an example of a widely used labelled property graph. Prior studies that made use of labelled 
property graphs for clinical data are summarized in Appendix 2.5. 
As graphs excel at emphasizing the importance of relationships between data, clinical 
questions that depend heavily on those relationships may be well suited to an LPG.82 Example data 
elements of interest include blood relationships between patients, or connections between 
symptoms and diseases.56 A relationship can also take the form of a temporal sequence (e.g., Event 
A occurred before Event B); thus, traversing a graph may be a natural way to query the trajectory 
and progression of a chronic disease.83 Farley, et al. take this one step further, suggesting that the 
relationships between some biological concepts are so complex as to require a hypergraph, where 




Graphs are also a natural representation for hierarchical ontologies. Campbell, et al. present 
the argument that when using SNOMED CT as an ontology, graph databases are not only a more 
efficient data store, but also enable the user to answer questions with semantic reasoning that 
would not be answerable in a relational context, at least without significant recursive joining. 
Moreover, graph databases support “data queries of ‘undefined depth’ and ‘undefined 
connections’,” which can reveal hidden patterns and perhaps contribute to serendipitous 
knowledge discovery.85 
2.4.4 Summary: NoSQL Technologies for Clinical Data 
The variety of findings described above do not suggest a clear “winner”; rather, it is clear 
that the optimal non-relational structure for clinical and clinical-adjacent data is highly dependent 
on the use case. Still, some clear trends emerge that may guide future use cases to gravitate toward 
one solution over others. Table 1 summarizes the affordances of each non-relational model as 
outlined by Kaur, et al. 
 
Table 1. Non-relational technologies and their ideal use cases, as posited by Kaur, et al.56 
Non-relational technology Best use case 
Key-value store Store/retrieve data items using a key 
Document store Retrieving/updating values associated with a key based on 
attribute(s) within the value 
Graph database Store/retrieve “friend-of-a-friend” (highly related) data 
Column store Store records with many attributes, but generally does not require 
narrowing to certain fields on retrieval 
 
 
Moreover, a variety of themes emerged as to why certain use cases are better-suited to a 
NoSQL technology than an RDBMS.  
2.4.4.1 Query Performance over High-Volume Data 
Studies that benchmarked NoSQL databases against relational databases in terms of query 
performance (that is, reads, and not necessarily writes) found that as the number of records 




Likewise, several studies cited various non-relational technologies’ high read performance over 
distributed architecture as an advantage. Distributed computing is highly scalable, and will likely 
become more essential over time as healthcare data continues to increase in size and scope. 
Those studies that incorporated genomics data had particular cause to optimize query 
performance. Genomic variant data is high volume and high velocity (as large amounts of variant 
data are produced rapidly by high throughput sequencing instruments), as well as high variability 
(due to different processing and evaluation needs depending on the type of variant and ultimate 
use case) that would lead to a high degree of sparseness in a relational architecture.59  
2.4.4.2 Working with Heterogeneous Data / Schemalessness 
Schemalessness, or tolerance of loosely modeled data, is a hallmark feature of all of the 
NoSQL technologies discussed here. Many studies specifically cited schemalessness as their primary 
reason for choosing a NoSQL technology; others saw it as one advantage among many. Because 
clinical data is dynamic, changing frequently with new discoveries, new regulations, and 
advancements in EHRs, a highly adaptable data model is advantageous. Moreover, a loose model 
may make it easier to link with external data sources, which likely have their own structure distinct 
from that of the clinical data. A loose model allows for much easier incorporation of these new 
structures, whether genomic data, geographically-based data, sensor data, or others. In contrast, 
altering the data model of a relational database can come at a high cost, either requiring adding 
columns to existing tables (and creating sparsity within existing tuples) or adding new tables, 
increasing the number of joins necessary for data retrieval.  
However, having no data model at all would be distinctly disadvantageous for clinical data. 
With no model, data validity would suffer (e.g., with three different ways to store blood pressure 
measurements, critical data could be easily missed in a query), and interoperability would be 
impossible. Many studies recognized this, and chose to use a standard clinical data model in tandem 




these studies) are specifically designed to accommodate changing requirements, and fit nicely 
within different NoSQL technologies. In this way, a NoSQL database using a standard data model is 
technically schemaless, but with guardrails.  
An additional advantage of schemalessness is the potential to store clinical data in its 
“native” format. Relational modeling of clinical data generally requires some degree of 
transformation from source systems in order to fit within the table structure. This transformation 
can naturally lead to loss of detail or granularity, particularly when data is imported from source 
systems that are very different in structure than the target database. This is particularly 
problematic for free-text clinical data, which does not “fit” in a relational database. Importing data 
in its raw format (or closer to its raw format) into a NoSQL database may allow for “lossless” 
extraction and loading, though some type of semantic mapping would still likely be necessary for 
effective querying.71  
2.4.4.3 Leveraging Semantics and Reasoning 
Linking clinical data with ontologies is not a given when using NoSQL technologies, but 
several studies took advantage of the ability to do so. Graph databases, specifically triplestores, are 
a natural fit for working with published ontologies, many of which are in graph structure. Mapping 
non-relational clinical data to an ontology helps to promote interoperability and complex querying 
based on logical reasoning. As noted by Haendel, et al., ontologies, which allow for the capability to 
query data at the concept level, are the key to effective use of extremely large clinical data stores to 
answer the question, “Have I seen a case like that?”36 
2.4.4.4 Highly Related Data 
NoSQL databases can also excel at storing and querying “highly related” data. This includes 
hierarchical data, where a relational database would require recursive joins to retrieve the parent 
of the parent of the parent of a given concept. This may also include situations where the 




relationship between a gene and a disease that changes in the presence of certain drugs, 
environmental exposures, and other gene variants. Triplestores and LPGs excel in this area 
specifically, due to their ability to materialize relationships as queryable concepts. Clinical data is 
relationship dense—diseases have causes, medications have side-effects, treatments have 
outcomes—and may be particularly well-suited to the graph structure for this reason. 
2.4.5 And What of Relational Databases? 
As can be seen by the continued dominance of relational databases in the healthcare 
domain, it should not be suggested that relational databases are incapable of addressing some of 
the limitations noted in the studies described here. (As an example, querying hierarchical data in a 
relational database may require large amounts of recursion, but with enough processing power, 
that may not be a limitation.) However, as the volume and complexity of data increases over time, 
the relational model may indeed begin to fall short. For this reason, continuing study of the 
technologies described is essential. 
Many of the studies described here focused on benchmarking query performance against 
the same dataset stored in a relational database and one or more NoSQL databases. Most of these 
efforts were not able to test the two solutions at a scale approaching a production healthcare 
database; as it is difficult to generate such a large amount of realistic test data, it is also difficult to 
execute a production-scale test as part of a research study. It is therefore difficult to determine how 
the results seen in these experiments would translate to a real-world implementation, with 
hundreds of millions (or billions) of records. Yet benchmarking studies may not be the future of this 
field of research; as seen above, there are reasons other than query performance why one might 
choose to use a NoSQL database for storage of clinical data. Further investigation into these 
affordances of NoSQL technology will help to determine whether production healthcare databases 




The current body of literature supports the vast potential of NoSQL technologies in the 
clinical data context. The focus should not be on replacing the relational database with NoSQL; 
rather, NoSQL can augment the capabilities of relational databases where NoSQL’s specific 
strengths are required. By leveraging the capabilities of NoSQL databases, as will be seen in the 
current study, we can undertake the new analytical challenges posed by big healthcare data, which 
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III. PRIOR WORK 
3.1 Introduction 
This chapter is a reproduction of a manuscript submitted to the Journal of Biomedical 
Semantics in June of 2020. As of this writing, the manuscript is in peer review. This manuscript 
provides important background on the Opioid Triplestore project that served as the foundational 
dataset and information infrastructure for the work described in this dissertation. The text of the 
paper is all my own work; the project itself, however, was a collaboration among myself and all of 
the authors listed below.  
Robert Bradford, North Carolina Translational and Clinical Sciences Institute, University of North 
Carolina at Chapel Hill, Chapel Hill, NC, USA 
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James P. Balhoff, Renaissance Computing Institute, University of North Carolina at Chapel Hill, 
Chapel Hill, NC, USA 
Rujin Wang, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 
USA 
John S. Preisser, Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, 
NC, USA 
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Permanente Northwest, Portland, OR, USA 
These individuals’ essential contributions (without which this project would not have been 
possible) are detailed in the “Author contributions” section. 
 Much of the literature review section of the original manuscript has been omitted here, as it 





Electronic health record (EHR)-based computable phenotypes (hereafter “computable 
phenotypes”) are algorithms used to query “data captured in the delivery of healthcare… to identify 
individuals or populations (i.e., cohorts) with conditions or events relevant to” some use case.1 An 
increasing number of clinical studies rely upon one or more computable phenotyping methods to 
define cohorts of interest.2  
Despite its importance, computable phenotyping suffers from a number of inefficiencies and 
pitfalls. Most methods rely solely upon the data available in the EHR, which is imperfect, suffers 
from missingness, may not represent the “true” patient state, and can be semantically ambiguous.1 
Another major barrier to achieving robust, sharable, machine readable computable phenotypes is 
the way in which most healthcare institutions choose to structure and store their EHR data—in 
siloed, relational data warehouses, disconnected from other potentially relevant data sources and 
structured according to a custom or vendor-specific data model.  
In this study, we describe our efforts to address some of these pitfalls as we executed a 
computable phenotype to identify previously opioid-naïve patients who became new chronic opioid 
users after a surgical procedure. This research question had complex data needs, with both an 
intricate phenotype requiring access to both EHR and claims data, as well as a need to link in 
community-level data for use in the eventual statistical model. Considering this complexity, we 
wanted to test whether this computable phenotype could be successfully run with SPARQL queries 
against a resource description framework (RDF) triplestore, rather than our standard method of 
running SQL queries against a relational database. In addition to determining whether the 
triplestore-driven phenotyping and data linkage approach was indeed feasible, we also sought to 






The study motivating our triplestore-driven phenotyping approach aims to devise a model 
to determine a previously opioid-naïve patient’s risk of becoming a new chronic opioid user after a 
surgical procedure resulting in an opioid prescription for post-operative pain. Before beginning 
work on the risk model, it was first necessary to define the computable phenotype to identify 
existing postsurgical new chronic opioid users, whose shared characteristics would enable us to 
define the risk model for future patients.  
The data sources used for both the phenotyping and the risk modeling effort included (1) 
UNC Health Care System EHR data; (2) claims data from a major commercial insurer in the 
Southeast; (3) American Community Survey (ACS) data (2012-2016);3 and (4) CDC Social 
Vulnerability Index (SVI),4 opioid prescription rate,5 and drug poisoning rate data (all 2016).6  
3.3.1 Phenotype Definition 
The criteria used to define new postsurgical chronic opioid users (adapted by author MN 
based on a prior study7) depends upon first applying criteria to the base population of surgical 
patients so that those with recent history of opioid use or prior opioid use disorder are excluded. 
These criteria are: 
 Patient has one CPT (procedure) code in the range 10000 – 69990 (the “surgery” range) 
between 4/14/2014 and 3/31/2017.  
 Patient does NOT have a second CPT code in the surgery range within six months (after) the 
index surgery. 
 Patient has at least one opioid prescription between 30 days prior to the index surgery and 
14 days after the index surgery. 
 Patient does NOT have an opioid prescription between 1 year prior and 30 days prior to the 




 Patient does not have a diagnosis code for “opioid use disorder” (ICD-9: 304.0X, 304.7X; 
ICD-10: F11.X) prior to the index surgery. 
 Patient had insurance with the commercial insurer from whom we obtained claims data at 
the time of the index surgery. (Not relevant to the patient’s status as a chronic opioid user, 
but necessary in this study to ensure linkage with available claims data.) 
Among the resulting set of previously opioid-naïve patients, we define new chronic opioid users as: 
 Patient has at least one opioid prescription between 90 and 180 days after the index 
surgery (suggesting that they are still using opioids well after the surgery at which they 
were originally prescribed).  
This rule-based computable phenotype is possible to implement with SQL code against EHR 
data—however, stopping at this single source of data would result in a skewed picture. This is 
because medication data is such an essential part of this phenotype—and as such, we care not only 
about medications that were prescribed by UNC physicians, but any medications that the patient 
may have received, from anywhere. In order to make use of non-UNC medication data, we needed 
to incorporate insurance claims data, which allowed us to work with a superset of patient 
medication data—all medications billed to the patient’s insurance, regardless of prescriber. 
Merging claims-based medication data with EHR-based medication data introduced one level of 
structural heterogeneity.  
To add further heterogeneity, we also recognized the need to incorporate community-level 
data sources in order to access socioeconomic data about the cohort for use in the risk model. While 
publicly available, these data sources are not available within UNC’s clinical data warehouse, and 
would have to be downloaded and modeled appropriately for incorporation with the EHR and 




Considering the challenges of incorporating these disparate data sources for unified 
analysis, as well as the affordances described earlier, our team decided on a triplestore approach.  
3.3.2 Data Transformation Pipeline 
As the three data sources are highly heterogeneous, we developed a transformation pipeline 
to take each data source from its raw form to RDF. This pipeline is illustrated in Figure 1, and 
described in detail in the text below. 
 
Figure 1. Data transformation pipeline to take EHR, claims, and geographically based datasets from 
their native formats to RDF, and integrate them in a Blazegraph triplestore. 
3.3.2.1 EHR Data 
UNC’s EHR data is sourced from the Carolina Data Warehouse for Health (CDWH), UNC 
Health’s enterprise clinical data warehouse. An analyst was tasked with extracting a cohort meeting 
the specifications of the rule-based computable phenotype listed above, with the exception of the 




for the risk model, we did not want to limit the cohort only to new chronic users at this point.) 
Because of the limitations of the EHR data, the resulting cohort was known to contain false positives 
(i.e., patients who qualified for the cohort using EHR data only, but would later be excluded based 
on claims data). 
We extracted EHR data for this cohort in the domains of patient demographics, encounter 
details, diagnoses, procedures, medications, smoking status, and pain scores. To convert the 
extracted data to HL7 Fast Healthcare Interoperability Resources (FHIR) format (version 3.0.1) we 
used CAMP FHIR,8,9 an open-source data conversion utility built to convert EHR data to FHIR 
format. Once the data were in FHIR format, we were able to use an open-source FHIR-to-RDF 
conversion utility10 to output the data in RDF and ready it for loading into the triplestore. 
3.3.2.2 Claims Data 
We produced a finder file containing identifiers for all of the patients identified from the 
EHR data, which an analyst used to perform a deterministic linkage with the claims cohort. 
Matching claims data were extracted in the domains of plan membership details, medications, 
diagnoses, and procedures. The latter three domains were converted to FHIR format using a Python 
script, and then converted to RDF using the same conversion utility as the EHR data. The plan 
membership data were manually converted to RDF using R,11 as it did not fit cleanly within the 
FHIR specification.  
3.3.2.3 Community Data 
Though non-clinical data was not required to run the computable phenotype to identify 
existing chronic users, the research team did want to include socioeconomic and other 
geographically-based factors in the eventual risk model. The chosen datasets (ACS and CDC SVI, 
opioid prescribing rate, and drug poisoning rate data) are all publicly available, but do not have a 
unified structure. For the purpose of querying these data within our triplestore, we minted custom 




3.3.2.4 Other Data 
Four additional datasets were loaded in order to aid querying and make connections 
between datasets in the triplestore. First was a patient-to-census-tract crosswalk, extracted from 
the EHR. Second, we loaded a census-tract-to-county crosswalk, to enable linkage with both tract-
based data (e.g., ACS) and county-based data (e.g., CDC opioid prescribing rates).  
Third, in order to consistently query medication data across EHR and claims data, we 
loaded a crosswalk between National Drug Codes (NDC) and RxNorm codes. Claims data uses NDC 
codes, which are representative of the exact medication dispensed by a pharmacy for a submitted 
claim, while UNC’s EHR medications are RxNorm coded. Using FHIR, it is possible to tie multiple 
codes to a single Medication resource where they share a common meaning. To accomplish this, we 
used a Python program called SMOREs12 to translate between NDC and RxNorm and stored both 
values within the same Medication resource that was subsequently converted to RDF.  
Finally, we loaded a subset of the Department of Veterans Affairs National Drug File 
(VANDF), crosswalked to RxNorm codes. This was loaded to make use of VANDF’s categorization 
scheme for medications in our queries, allowing us to query by high-level medication categories 
(opioids, benzodiazepines) rather than matching on hundreds of individual RxNorm codes. 
After each data source (EHR, claims, community, other) was converted to RDF, we loaded 
each RDF file into a Blazegraph13 triplestore.  
3.3.2.5 Phenotyping with SPARQL 
We wrote a series of SPARQL queries to execute the same rule-based logic as the original 
SQL queries that extracted the EHR-based cohort. Because the data were now integrated, running 
the same logic a second time could (and did) exclude patients who had originally qualified for the 
EHR cohort. Examples of such situations included patients who didn’t have a disqualifying pre-




data, and patients who only had one surgical procedure in a six-month period in UNC’s EHR data, 
but whose claims data showed an additional (disqualifying) procedure at another institution.  
A final SPARQL query was written to implement the final rule of the phenotype (the 
presence of an opioid prescription between 90 and 180 days after the index surgery), which would 
define our outcome variable for each patient in the cohort: CHRONIC_USER_YN.  
3.4 Results 
The number of triples loaded into Blazegraph from each data domain are listed in Table 1.  
Table 1. All data domains included in the Blazegraph triplestore, with number of triples. 
Data Source Data Domain Format # of Triples Loaded 
EHR Patient FHIR 341,248 
 Encounter  FHIR 18,180,947 
 Procedure FHIR 10,158,248 
 MedicationRequest FHIR 80,017,422 
 Medication FHIR 549,175 
 Observation (vitals & smoking status) FHIR 57,412,289 
 Condition FHIR 100,614,527 
Claims Plan membership data Custom 12,417 
 MedicationDispense FHIR 22,176,831 
 Medication FHIR 629,928 
 Procedure FHIR 16,483,352 
 Condition FHIR 12,155,855 
Geographically 
Based 
CDC SVI* Custom 256,464 
 CDC opioid prescribing rates* Custom 98 
 CDC drug poisoning rates* Custom 200 
 American Community Survey*⟊ Custom 2,265,240 
Other Census tract to county crosswalk* Custom 2,195 
 Patient to census tract crosswalk Custom 4,157 
 Department of Veterans Affairs 
National Drug File (opioid and 
benzodiazepine categories only) to 
RxNorm crosswalk 
Custom 1,438 
* Despite national information being available, only North Carolina data was loaded for the 
purposes of this study. 
⟊ Only a subset of the available American Community Survey variables were loaded for the 
purposes of this study. 
 
We initially loaded 15,954 patients that qualified as previously opioid-naïve patients with a 




loaded and the computable phenotype (except for the final rule) was re-executed over the 
integrated data using SPARQL, the number of qualifying patients dropped to 4,163. The reasons for 
this drop are illustrated in Figure 2.  
 
Figure 2. Illustration of cohort narrowing as phenotype rules were applied in the triplestore. 
Of the 4,163 patients in the final cohort, 248 patients were identified as new chronic opioid 
users after their index surgical procedure. Patient identifiers for this group were given to two 
clinicians to manually chart review in order to validate the actual presence of new chronic opioid 
use in the patient’s record. Of the 248 patients identified by the phenotype, 228 were found to be 
true new chronic users through chart review. The remaining 20 patients qualified for the 
computable phenotype, but upon review of their charts, the procedure defined as their index 
surgery (which qualified them for the cohort) appeared not to have truly been a “surgery,” despite 
being coded in the surgical range. One possible explanation for this is that the CPT “surgery” range 




considering certain events as “surgeries” when a clinician would not see them as such. Based on 
these results, this computable phenotype has a positive predictive value of 0.92 for identifying new 
chronic opioid users after surgery. 
Of the 248 patients identified as new chronic opioid users, 16 were identified by EHR data 
alone, 39 were identified by both EHR and claims data, and 193 were identified by claims data 
alone. (“Alone,” in this case, means that while the patient had data in both the EHR and claims, the 
opioid prescription(s) that qualified them as a new chronic user between 90 and 180 days from 
their index surgery] was only present in one of the two sources.) 
4,121 of the 4,163 patients were able to be linked with a census tract and county, based on 
their address recorded in the EHR as of March 31, 2017 (the end of the study period). This enables 
us to connect these patients with a selection of socioeconomic variables (including Social 
Vulnerability Index, drug poisoning rate, and unemployment rate) for potential inclusion in the new 
chronic opioid user risk model. 
3.5 Discussion 
3.5.1 Primary Results 
Our main finding is that triplestores are an effective platform for complex computable 
phenotyping, enabling cross-querying among heterogeneous datasets and offering some 
functionality beyond that of a relational database. For this particular phenotyping project, 
combining claims data with EHR data was particularly advantageous, allowing us to identify many 
more patients qualifying for the phenotype than using EHR data alone. Converting the EHR data and 
the claims data to a common format (FHIR, then RDF) and loading it in a triplestore made 
integration and cross-querying very straightforward, essentially like querying a single source of 
data.  
It is worth noting that for a dataset of this size and scope, use of this triplestore-driven 




future work (detailed below) involving phenotypes that require (or could benefit from) the 
inclusion of much larger and varied ontologies and datasets (e.g., the Human Phenotype Ontology, 
the entirety of SNOMED CT, the Gene Ontology, etc.).  
3.5.2 Advantages of the Triplestore Approach 
3.5.2.1 Schemalessness 
The triplestore’s schemalessness proved particularly valuable in the context of the 
community datasets. Beyond converting from CSV to RDF format, almost no transformation was 
needed to prepare these data sources for ingestion in the triplestore. Should we have found 
additional publicly available data sources that we wanted to use, it would have taken very little 
effort to incorporate them. This capability holds a lot of promise for future studies, particularly due 
to the recognition of the importance of social determinants of health variables, which are often 
absent in EHR and claims data, in clinical research.14–18  
3.5.2.2 Interoperability and Reproducibility  
The FHIR representation standard is becoming increasingly supported by major EHR 
vendors—in effect, forcing institutions to standardize their data. In addition to defining specific 
resources and fields, FHIR enforces the use of established code sets (e.g., LOINC, SNOMED CT, ICD-
9/-10) or FHIR-specific value sets in many of its fields in order to maximize standardization. 
However, as FHIR data exists in flat files (JSON- or XML-formatted), it is not inherently “queryable” 
unless additional processing steps are taken. In this case, loading FHIR data in a triplestore enables 
its use for computable phenotyping. 
The interoperability benefits of FHIR, compared with the interoperability (by definition) of 
semantic web technologies, enabled us to create a phenotype that should be transferrable to any 
other site with few local changes, so long as the institution can output EHR data in FHIR format. 




claims data interoperable despite their native formats being completely different.) As FHIR moves 
toward becoming a lingua franca for EHR data, FHIR-based phenotypes such may gain 
reproducibility advantages over phenotypes that run against institution-, data network- or vendor-
specific data models. 
3.5.3 Limitations and Lessons Learned 
Because the FHIR format creates an enormous number of triples (as shown in Table 1), it 
would seem to be a best practice to narrow down the initial cohort as much as possible before 
transformation to RDF. It would be less feasible to try to persist an entire clinical data warehouse in 
RDF. Similarly, within a given data domain (particularly a large one, like Condition), it would be 
more efficient to pare down the set of diagnoses to only those needed for the given research 
question prior to loading. With that said, if a study’s objective is less targeted and more exploratory, 
this may not be desirable. For such a use case, sufficient resources to load and compute over all 
those triples would be the primary concern. 
Additionally, as with any use case that involves data transformation, there is always a 
chance that information can be lost over the course of the transformation pipeline. For this reason, 
we took the time to validate our final cohort against the source data system (the EHR), and would 
advocate doing so for future cohorts identified in this way. 
3.5.4 Future Work 
Now that the computable phenotype has been executed, statistical analysis has commenced 
in order to establish a risk model that can be applied to patients de novo. This work will occur 
outside of the triplestore. In parallel with this effort, we identified several new directions to take 





We see great potential in leveraging additional ontologies (other than the medication 
ontologies used in this study) in future work. Ontologies allow users to work with information at 
both the “data level” and the “knowledge level.”19 As data at the knowledge level is not often stored 
in the EHR itself, the ability to link to external sources containing that knowledge adds richness to a 
clinical data store.20–22  
“OWL reasoning,” another capability afforded by RDF, is an extension of this knowledge 
level, in that new assertions can be concluded based on existing assertions in the triplestore.23–25 
For this project specifically, we used a small subset of VANDF to query medications at the 
knowledge level to enable easier querying (e.g., querying by rolled-up categories rather than 
hundreds of individual medication codes). With this success in mind, we believe that linking with 
ontologies and leveraging OWL reasoning could potentially reveal new hypotheses to explore, via 
patterns in the data that may be hidden at the individual medication code level. 
Use of standard ontologies also can enable linkage with other external datasets, in addition 
to the community data we used here. Additional external data sources may include one or more of 
the datasets available on the web as Linked Open Data, or LOD, an open data repository expressed 
in triples. Many of the datasets available as LOD are biomedical in nature, and could allow one to 
link EHR data with public data to discover, for example, gene-disease associations, genotype-
phenotype associations, or drug-drug interactions.20,26–28  
3.6 Conclusion 
Though computable phenotypes are written, executed, and shared with great frequency 
today, computable phenotyping as a discipline has not yet reached the ideal of consistently 
producing phenotypes that are interoperable, reproducible, and capable of integrating 
heterogeneous data sources. Some of these challenges may be addressed by exploring alternatives 
to siloed, relational data warehouses for storage and analysis of clinical data. Semantic web 
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I devised two experiments to answer the following research questions: 
 
Research Question 1: Can clinical ontologies (specifically SNOMED CT and the Human 
Phenotype Ontology) offer a less semantically ambiguous mechanism to perform computable 
phenotyping than reimbursement-focused terminologies (specifically ICD-10-CM)? 
 
Research Question 2: Does the use of semantic web technologies and standards (e.g., Resource 
Description Framework (RDF), triplestores, the Web Ontology Language) in tandem with 




Figure 1 is a “map” of both experiments, from initial data cleaning steps through query 
results; this map will be used throughout this chapter to visually orient the reader.  
 
 




At a high level, the experiments can be described as follows: 
 
1. A SPARQL-based comparison of the performance of validated, ICD-10-CM-based 
computable phenotypes (for depression and rheumatoid arthritis, respectively) with the 
performance of equivalent computable phenotypes using SNOMED CT and HPO. The patient 
data in the existing Opioid Triplestore, described in Chapter 3, was used as a testbed.  
2. Construction and testing of an open-source data processing pipeline to take clinical and 
clinically relevant data from its native format to RDF and OWL, and load the resulting data 
in a Blazegraph triplestore. 
 
This chapter describes tools and methods used to execute each step of both experiments. 
4.2 Software and Data Sources 
4.2.1 Ontologies/Terminologies  
4.2.1.1 UMLS 
The Unified Medical Language System (UMLS) is an umbrella term describing a collection of 
mapping files and software maintained by the US National Library of Medicine that allow users to 
cross-reference multiple biomedical vocabularies.1 For this project, SNOMED CT files were 
downloaded under a UMLS license.  
4.2.1.2 SNOMED CT 
SNOMED CT is a common language for describing and analyzing disparate sources of clinical 
data, and supports both general and highly specific concepts.2 The US Edition is provided by the US 
National Library of Medicine (NLM), and is available to UMLS licensees. SNOMED CT US Edition, 
version 20190901 (September 2019) was used for this project.3 
SNOMED’s hierarchical structure means that it is difficult to store and analyze in a relational 
database, though as discussed in Chapter 2, SNOMED data is often stored in a relational database as 




child concepts can be maintained, but queries against other concept relationship types (negation, 
disjunction, etc.) are not possible. For this reason, SNOMED is a natural fit for a graph database, as 
shown in this and other research.4 
4.2.1.3 ICD-10-CM 
The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-
CM) is a classification scheme for diseases and injuries that is used worldwide for epidemiology, 
statistical reporting of mortality and morbidity, and reimbursement purposes.2 As ICD-10-CM is the 
standard coding scheme for diagnoses in the United States, ICD-10-CM codes are featured 
prominently in computable phenotypes. ICD-10-CM codes are between three and seven digits 
(alphanumeric characters), with the first three digits signifying the disease category, the fourth 
through sixth (optional) digits signifying etiology, anatomic site, or severity, and the seventh digit 
signifying the encounter (initial, subsequent, or sequela). Depending on the code, the seventh digit 
can be required, even if prior optional digits are not used.5 
As part of its work with SNOMED, NLM maintains a mapping table between SNOMED and 
ICD-10-CM. To create and maintain these mappings, terminology specialists independently map the 
two terminologies (i.e., decide which concepts are equivalent), accept mappings where they agree, 
and resolve disagreements using a third expert.6 The SNOMED to ICD-10-CM mapping provided as 
part of SNOMED version 20190901 was used for this project.3 
The mapping between SNOMED and ICD-10-CM is not fully machine readable; the map’s 
ability to generate ICD-10-CM codes from SNOMED codes is described as “semi-automatic” by its 
creators.2 Because of the major differences in purpose and granularity between SNOMED and ICD-
10-CM, many of the mappings are context dependent and cannot be used without further 





Table 1. A context-dependent mapping of the SNOMED concept “Maternal tobacco use in 
pregnancy.” A granularity difference between SNOMED and ICD-10-CM requires knowing whether 
the user is describing tobacco use complicating childbirth or pregnancy in order to get the most 
accurate map—note the “Mapping advice” column. 
 
SNOMED Code SNOMED 
description 


















































Even when a mapping exists, an additional complication occurs when a SNOMED code is 
mapped to an ICD-10-CM code that requires the seventh digit. Because the SNOMED concept does 
not account for the concept of an “encounter,” there is no accurate way to choose the proper 
seventh digit for the mapped ICD-10-CM code. In these cases, the mapping document replaces the 
seventh digit with a “?” and uses the placeholder “X” for non-required prior digits. An example is 
shown in Table 2. 
 

















ALWAYS V29.9XX? | 
EPISODE OF CARE 
INFORMATION NEEDED | 
THIS IS AN EXTERNAL 
CAUSE CODE FOR USE IN A 
SECONDARY POSITION 
V29.9XX? Motorcycle rider 
(driver) (passenger) 
injured in unspecified 
traffic accident, 






As the ICD-10-CM codes are not being used for the purposes of reimbursement in this study, 
compliance with the episode of care specification requirement is less important. What is important, 
however, is to handle these cases consistently, and to ensure that the chosen solution will be able to 
be mapped to ICD-10-CM codes used in EHR data. 
4.2.1.4 Human Phenotype Ontology 
Comparing and analyzing the expressions of various diseases, or their “phenotypic 
features,” may allow researchers to identify disease families, or groups of diseases with overlapping 
features. The Human Phenotype Ontology (HPO) was built with the objective of describing all 
phenotypic abnormalities expressed by diseases, to allow researchers to compute phenotypic 
similarities between diseases.7 It also enables a wide range of linkages with other ontologies such 
as Orphanet (rare diseases), the Gene Ontology (genes), Uberon (anatomy), and several others. In 
this way, the purpose of HPO is different from that of SNOMED, though HPO maps many of its 
concepts to SNOMED concepts. The November 2019 release of HPO was used for this project.8  
4.2.2 Software  
4.2.2.1 Protégé 
Protégé is an open source ontology editor developed by the Stanford Center for Biomedical 
Informatics Research. Protégé allows users to browse through ontologies using a graphical user 
interface (see Figure 2), as well as run various reasoning tools to assert and add new information to 





Figure 2. Screenshot from Protégé 5.5 illustrating the inclusion of the ICD-10-CM mappings as 
assertions in the SNOMED CT ontology.  
4.2.2.2 HermiT OWL Reasoner 
In order to fully take advantage of the information stored in a triplestore augmented with 
an ontology, it is necessary to look beyond the asserted triples in the ontology and the data. 
Depending on the ontology, there could be many additional triples that can be inferred from the 
asserted axioms. As an example, consider the following triples that describe familial relationships: 
Define “hasParent” as a subproperty of “hasAncestor,” and declare “hasAncestor” to be a 
transitive property: 
:hasParent   rdfs:subPropertyOf   :hasAncestor 
:hasAncestor   rdf:type   owl:TransitiveProperty 
 
Apply this logic to the following (asserted) triples: 
:Susan   :hasParent   :Eleanor 
:Eleanor   :hasParent   :Rose 
 
Because :hasAncestor is a transitive property, the following triples can be inferred even if they 
are not explicitly asserted: 
:Susan   :hasAncestor :Eleanor 
:Eleanor   :hasAncestor   :Rose 




Though it could be argued that the first two of the above triples are somewhat redundant, the third 
(connecting Susan directly with Rose) is new information that could be useful in a query.10 
There are a variety of ways to calculate these inferred triples. This project makes use of the 
HermiT OWL reasoner11 to do so. Figure 3 shows the same concept from Figure 2, after the HermiT OWL 
reasoner has asserted two new triples. 
 
Figure 3. Screenshot from Protégé 5.5 of the same concept shown in Figure 2, after running the 
HermiT reasoner to add inferred axioms (the SubClass Of axioms at the bottom). 
 
4.2.2.3 Blazegraph and GraphDB 
Blazegraph (formerly known as Bigdata) is an open-source triplestore designed to scale over 
unlimited compute nodes for use with very large RDF datasets.12 (Though a single server was used 
for this project, in theory additional machines would improve query performance.) Blazegraph 2.1 




generate graph visualizations. Any graph visualizations appearing as figures in these chapters were 
generated using GraphDB (version 9.0.0), another triplestore with a robust Visual Graph feature. 
4.2.2.4 KNIME 
KNIME (Konstanz Information Miner) is an open-source data science platform that allows 
the user to chain together modular data processing steps into a cohesive pipeline. I used KNIME to 
construct, document, test, and package the pipeline to transform raw FHIR and CSV input data into 
an integrated triplestore. KNIME 4.1.0 was used for this project.13 
4.2.2.5 FHIRToRDF 
FHIRToRDF14 is an open-source utility that can be used to convert FHIR files (version 2 or 3 
at the time of this writing) to RDF. 
The utility’s modeling “decisions” 
are based on the FHIR metadata 
vocabulary, publically available at 
build.fhir.org/fhir.ttl. Figure 4 shows a small excerpt from the metadata vocabulary, showing how 
the concept of “condition abatement date/time” (that is, when a patient’s disease or condition was 
resolved) should be modeled in RDF. FHIRToRDF is an integral part of the data transformation 
pipeline that constructs the triplestore used in this project. 
4.3 Ontology Pre-Processing 
A number of pre-preprocessing steps were necessary before the ontologies were loaded 
into the triplestore for analysis. 
4.3.1 Download Ontology Files 
Individual ontology files were downloaded from the sources in Table 3.  
 
 




Table 3. Ontology files and their online sources 












4.3.2 Conversion of SNOMED to OWL 
SNOMED does not offer a downloadable OWL file 
with each of its versions, though SNOMED International 
recognizes that many users ultimately want to use the 
ontology in OWL format. Thus, SNOMED International offers an “official” open-source utility to 
transform the raw downloaded ontology to OWL (available at https://github.com/IHTSDO/snomed 
-owl-toolkit). I executed this process in order to produce an OWL version of SNOMED for use in 
Protégé.  
4.3.3 Mapping SNOMED to ICD-10-CM 
The SNOMED download includes a 
separate CSV document containing the mappings 
between SNOMED and ICD-10-CM, which required 
cleaning and pre-processing before it could be 
used in Protégé. First, I needed to remove all context-dependent mappings, as in the current study, 
the additional information required to resolve context-specific mappings will not be knowable. (See 
Table 1.) For this reason, I excluded all rows from the mapping document with a mapCategoryName 
of “MAP OF SOURCE CONCEPT IS CONTEXT DEPENDENT.” Additionally, I eliminated rows with a 
mapCategoryName of “MAP SOURCE CONCEPT CANNOT BE CLASSIFIED WITH AVAILABLE DATA,” 




would be SNOMED concepts designating “normal” findings, which have no equivalent in ICD-10-CM 
due to the latter’s focus on disease and injury.) 
After removing these rows, the remaining rows represented a many-to-one relationship 
between SNOMED codes and ICD-10-CM codes. (See Figure 5.) This was the set that I ultimately 
wanted to load into the triplestore for cross-ontology linkage, and therefore required me to convert 
from its native CSV format to triples. To do so, I needed to choose an appropriate predicate to link 
each SNOMED code with its accompanying ICD-10-CM equivalent. After reviewing available 
predicates in the RDF schema and the Simple Knowledge Organization System (SKOS), I opted to 
use skos:closeMatch. According to W3C, skos:closeMatch “indicates that two concepts are 
sufficiently similar that they can be used interchangeably in applications that consider the two 
concept schemes they belong to. However, skos:closeMatch is not defined as transitive, which 
prevents such similarity assessments to propagate beyond these two schemes.”15 I used a Python 
script (later included as a module in the data processing pipeline) to transform the mapping file to 





Figure 5. Once merged, many SNOMED codes map to the same ICD-10-CM code. 
 
Box 1. Sample triples from the custom SNOMED CT to ICD-10-CM mapping. 
###  http://snomed.info/id/10000006 
<http://snomed.info/id/10000006> rdf:type owl:Class ; 
                                 rdfs:subClassOf [ owl:intersectionOf (  
                                     <http://snomed.info/id/29857009> 
                                     <http://snomed.info/id/9972008> 
                                                                      ) ; 
                                                   rdf:type owl:Class 
                                                 ] ; 
                                 rdfs:label "Radiating chest pain  
                                     (finding)"@en ; 
                                 skos:closeMatch fhir:R07.9 ; 
                                 skos:prefLabel "Radiating chest pain"@en . 
 
Once the SNOMED to ICD-10-CM map was in OWL format, I was able to manually paste its 
contents into the master SNOMED OWL file created in an earlier step, creating a merged OWL file 
that included all of SNOMED in addition to the ICD-10-CM mappings. (Note the addition of 




4.3.4 Importing into Protégé, Reasoning, and Exporting  
 
I imported the merged SNOMED file into Protégé, and used the HermiT OWL reasoner to 
infer new triples. I then exported the resulting merged ontology with both asserted and inferred 
triples in TTL format (a highly readable variation of RDF), and loaded it into the triplestore for 









Figure 6. Beginning with the node “Joint Pain” (circled in green), SPARQL queries against the merged, reasoned-over ontology allow us to 
reach all SNOMED codes that are subclasses of Joint Pain (red), as well as the ICD-10-CM mappings associated with those subclass nodes 




4.3.5 Loading HPO 
HPO is downloadable in RDF, and already includes links to other ontologies 
(including SNOMED CT). These links are made via the predicate 
“http://www.geneontology.org/formats/oboInOwl#hasDbXref”. Because of these 
existing links, the HPO file did not require any pre-processing, and could be loaded 
into the triplestore directly from download. See Figure 7 for a visualization of the 
graph of the merged SNOMED/ICD-10-CM ontology when HPO is added. 
4.4 Experiment 1: Comparing Computable Phenotype Performance: ICD-10-CM Code 
Matching versus Ontology-Driven Queries 
The Phenotype Knowledgebase (PheKB) is a 
well-regarded phenotype sharing solution developed 
by the Electronic Medical Records and Genomics 
(eMERGE) network, a consortium of institutions funded 
by the National Human Genome Research Institute to 
combine DNA biorepositories with EHR data. 
Organizations are encouraged to use PheKB to share validated computable phenotypes with 
enough detailed documentation to allow other institutions to locally replicate the phenotype logic.16 
For this project, PheKB served as the source of ICD-10-CM codes to define two phenotypes, for 
depression and rheumatoid arthritis. The objective of this experiment was to compare the 
“coverage” of a computable phenotype defined by a list of ICD-10-CM codes (from PheKB) against a 
phenotype defined by a single concept (along with its child concepts) from the SNOMED or HPO 
ontology. Measuring the sensitivity and specificity of the phenotype methods is not possible in this 
study, as there is no way to know who the “true” cases are—we can only know which patients are 
identified by each phenotyping method. What is critical to measure, then, is the degree to which the 








Figure 7. Expanding on Figure 6 to include HPO (within the orange outline). HPO links to SNOMED through a database cross reference—




 Note that because HPO maps directly to SNOMED, despite necessitating different SPARQL 
queries for use in phenotyping, the patient set resulting from HPO and SNOMED queries will always 
be the same. Thus, I often refer to these two ontologies in combination, as “SNOMED/HPO.” The 
rationale for including HPO in this experiment despite the identical results to SNOMED is addressed 
in Chapter 6.  
4.4.1 The Depression Phenotype 
In the Opioid Triplestore project, there was a need to identify the subset of patients with 
mood disorders in order to determine if comorbid mood disorders are a risk factor for developing a 
dependency on opioids prescribed post-surgery. Without the aid of ontologies, it is necessary to run 
a SPARQL query containing each of a list of ICD-10-CM codes in order to identify the depression 
cohort within the triplestore—in this case, a list of codes derived from the Depression phenotype 
hosted by PheKB.17 This SPARQL query is shown in Box 2, below. (Hereafter, this will be known as 
the “PheKB depression query.”) 
Box 2. The PheKB depression query to identify the depression cohort in the Opioid Triplestore 
using individual ICD-10-CM codes (listed in the WHERE clause). 
 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX fhiricd: <http://hl7.org/fhir/sid/icd-10-cm/> 
 
SELECT distinct ?patient 
FROM <http://tracs.unc.edu/opioid_triplestore/clinical/condition> 
WHERE { 
 ?cond fhir:Condition_subject / fhir:link ?patient . 
   ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a ?jpcode . 
      FILTER(?jpcode IN (fhiricd:F32.3, fhiricd:F33.3, fhiricd:F32.0,     
         fhiricd:F32.1, fhiricd:F32.2, fhiricd:F32.4, fhiricd:F32.5,  
         fhiricd:F32.9, fhiricd:F33.0, fhiricd:F33.1, fhiricd:F33.2,  
         fhiricd:F33.40, fhiricd:F33.41, fhiricd:F33.42, fhiricd:F33.9,  
         fhiricd:F32.89, fhiricd:F33.8, fhiricd:F43.21)) 
      } 
 
Once the integrated SNOMED and HPO ontologies were loaded into the triplestore, it 




depression cohorts without the need to list specific individual codes. (Hereafter these will be 
known as the “SNOMED depression query” and the “HPO depression query,” respectively.)  
Box 3. The SNOMED depression query to identify the depression cohort in the Opioid Triplestore. 
 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
 




      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?snomednode = snomed:35489007) #the snomed code for Depression 
      } 
 
Box 4. The HPO depression query to identify the depression cohort in the Opioid Triplestore. 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> 
PREFIX hpo: <http://purl.obolibrary.org/obo/> 
 





      ?hponode oboInOwl:hasDbXref ?xrefnode . 
      BIND(REPLACE(?xrefnode,"SNOMEDCT_US:","http://snomed.info/id/") as  
         ?xrefnode2) . 
      BIND(IRI(?xrefnode2) as ?snomednode) . 
      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?hponode = hpo:HP_0000716) #the hpo code for Depression 





4.4.1.1 Comparing the Included ICD-10-CM Codes 
The first step in comparing the performance of the phenotyping methods to is examine 
which codes are used to define depression in each case. Ultimately, all three methods (PheKB, 
SNOMED, and HPO) result in a list of ICD-10-CM codes to match against the triplestore—but while 
the first method gives the user the exact list of codes to use, the latter two methods define that list 
by traversing a graph to find child concepts and their equivalent ICD-10-CM codes. If the mappings 
between SNOMED/HPO and ICD-10-CM for the concept of depression (and its children) are either 
less or more complete than the PheKB code set, the codes (and any resulting patient cohorts) will 
differ. 
Discovering the list of depression codes is a simple task with the ICD-10-CM code set from 
PheKB, as the codes are defined as part of the phenotype documentation. Determining the codes 
used as part of the SNOMED and HPO queries, however, requires us to traverse the graph of our 
integrated ontology, and determine which codes are nested underneath the high-level ontology 
concepts for depression from SNOMED and HPO. Box A1 in Appendix 4.1 contains the code to 
retrieve the individual codes in each set from the triplestore. See Chapter 5 for the lists of codes 
included in each set.  
When comparing which codes are included in each set, it is not useful to discuss in terms of 
what codes are “correct” versus “incorrect.” Which codes are most useful for a computable 
phenotype is heavily influenced by the use case, and what the user or investigator is trying to 
accomplish. For example, the PheKB depression phenotype does not include a code for postpartum 
depression, whereas HPO does. However, whether one wants to include postpartum depression in a 
depression phenotype will depend on the study. Thus, while it is not possible to determine the 
overall “correctness” of each set of codes, it is possible to make some general observations on the 




4.4.1.2 Comparing the Identified Patients 
In addition to comparing the depression code sets defined by PheKB and SNOMED/HPO, it 
is equally important to examine the results of identifying a patient cohort using each of those code 
sets. There are many ICD-10-CM codes that may not be regularly used in practice—thus, even if a 
code appears in one of the code sets and not the others, if that code never matches a patient record, 
the code’s presence in the set has no impact on the resulting cohort. For this study, the patient data 
in the Opioid Triplestore is used as a test bed for each of the code sets. The cohort definition for the 
Opioid Triplestore is relatively generic, if logically complex, essentially including all patients with a 
particular insurance provider who had surgery and were prescribed at least one opioid in the 
specified time period. The cohort is therefore disease agnostic, and is suitable for this experiment. 
In order to compare the patient graphs that result from the PheKB and SNOMED/HPO 
depression queries against the EHR data in the Opioid Triplestore, I first created named graphs to 
contain the respective query results, shown in Box A2. (Because the SNOMED and HPO codesets are 
identical, a single named graph was sufficient to capture results for both.) Once these graphs are 
populated, a simple SPARQL query can compare them to determine which patients are in one and 
not the others; an example of one such query is shown in Box A3.  
To validate these query results, it was necessary to ensure that the patients identified by 
one query and not the other were patients who were associated with the ICD-10-CM codes mapped 
in one query and not the other. The SPARQL query in Box A4 shows how to run this test in one of 
the two directions, as an example—to examine the depression codes associated with the patients in 
the SNOMED/HPO depression cohort who are not in the PheKB depression cohort. 
4.4.2 The Rheumatoid Arthritis Phenotype 
In the Opioid Triplestore project, there was also a need to identify the subset of patients 
with preexisting pain diagnoses in order to determine if comorbid chronic pain is a risk factor for 




chronic pain, and also has a phenotype hosted on PheKB, making it a good test case for this study. I 
undertook the same cohort comparison steps for RA as for depression. 
4.4.2.1 Comparing the Included ICD-10-CM Codes and the Identified Patients 
Comparing the RA codes used in each phenotype and the patients matched by each 
proceeded in the same way as with the depression phenotype. The PheKB, SNOMED, and HPO 
SPARQL queries to identify the RA patient cohort are shown in Boxes 5, 6, and 7 below.  
 
Box 5. The PheKB RA SPARQL query. Note the need to regular expression match on the ICD-10-CM 
code, as the PheKB phenotype expresses its ICD-10-CM codes as “M05*” and “M06*” (meaning “all 
codes that begin with…”) rather than listing exact codes. 
 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX fhiricd: <http://hl7.org/fhir/sid/icd-10-cm/> 
 
SELECT distinct ?patient ?racode 
FROM <http://tracs.unc.edu/opioid_triplestore/clinical/condition> 
WHERE { 
 ?cond fhir:Condition_subject / fhir:link ?patient . 
   ?cond fhir:Condition_code / fhir:CodeableConcept_coding /  
         fhir:Coding_code / fhir:value ?racode 
   FILTER(regex(?racode, "M05", "i") || 
         regex(?racode, "M05[.]{1}[0-9]*", "i")  || 
         regex(?racode, "M06", "i") || 
         regex(?racode, "M06[.]{1}[0-9]*", "i") 
          ) 
} 
 
Box 6. The SNOMED RA SPARQL query. 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
 




      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?snomednode = snomed:69896004) #the snomed code for RA 





Box 7. The HPO RA SPARQL query. 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> 
PREFIX hpo: <http://purl.obolibrary.org/obo/> 
 





      ?hponode oboInOwl:hasDbXref ?xrefnode . 
      BIND(REPLACE(?xrefnode,"SNOMEDCT_US:","http://snomed.info/id/") as  
         ?xrefnode2) . 
      BIND(IRI(?xrefnode2) as ?snomednode) . 
      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?hponode = hpo:HP_0001370) #the hpo code for RA 
      } 
 
See Chapter 5 for a detailed analysis of the RA test outcomes. 
4.5 Experiment 2: Building the Transformation Pipeline 
In order to ensure the extensibility and interoperability of this methodology, it is necessary 
to construct a reproducible data transformation “pipeline” that breaks the processes of data 
cleaning, data formatting, and data loading described in 4.3 into individual, repeatable steps. The 
full pipeline, constructed in KNIME, has been uploaded to GitHub at https://github.com/empfff/ 
clinical-tripleizer. As KNIME allows for documentation directly on the pipeline itself, details such as 
system prerequisites and various explanatory notes are shown as annotations on the pipeline, 




4.5.1 Convert CSV data to RDF/OWL 
The pipeline assumes that the user will have one or more datasets in CSV format that need 
to be transformed to RDF or OWL before moving forward. (If this is not the case, this step is 
optional.) The first node in this step (see Figure 8, 
“Configure input CSV”) serves as a kind of configuration 
file, where the user can preset all of the variable parts of 
the pipeline—the local file paths; the columns containing 
subjects and objects; and the desired prefixes to append to 
subjects, objects, and predicates.  
Once the configuration node is set, the user can run 
either the TTL or OWL conversion nodes to read the 
source file, convert the data as specified, and write out the 
resulting TTL/OWL file to the path given. 
4.5.2 Convert FHIR data to RDF 
The pipeline also assumes that the user’s clinical data will be in FHIR (JSON) format. (This is 
a reasonable assumption, as FHIR files can be output from EHRs.) At this time, FHIR versions 2 and 
3 are supported. The FHIR files must be converted to RDF before they can be loaded in a triplestore; 
to do this, the pipeline makes use of the FHIRToRDF utility. Because FHIRToRDF is a command-line 
utility, the function of the pipeline is to generate a custom shell script to run the utility as many 
times as needed to convert as many FHIR files (in as many FHIR domains) as the user has. As with 
the prior step, this part of the pipeline has a configuration node to specify paths, FHIR resources, 
and other variables prior to running the Python-based conversion node. The output of this step is a 
set of RDF files—one RDF file per FHIR data domain. See Figure 9 for an example set of RDF files 
output by this pipeline step. 




4.5.3 Generate a script to load RDF data into Blazegraph 
Once all data is converted to RDF, it can be loaded into Blazegraph. Blazegraph’s DataLoader 
is also a command-line utility, so as with the FHIRToRDF step, the function of this piece of the 
pipeline is to use a configuration 
node and a Python script to 
generate a custom shell script that 
will load the user’s datasets into 
the triplestore. 
4.5.4 Load data and run test queries 
The pipeline also includes an (optional) step to upload the generated shell scripts to a 
remote server, if that applies to the user’s situation. If everything is to be run locally, this step is not 
necessary. Whether or not that step is run, the final step is for the user to run both shell scripts (the 
FHIRToRDF conversion shell script and the Blazegraph DataLoader shell script, in that order). The 
result is a loaded triplestore, ready for the execution of test queries. 
 
Figure 9. Output of FHIRToRDF. Note the (expected) 
differences in file sizes among the various resources, 
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Chapter 4 described the methods used to prepare for and execute two computable 
phenotypes, for depression and rheumatoid arthritis. In this chapter, we compare the results of 
executing the ICD-10-CM-based phenotypes with those of the equivalent SNOMED/HPO 
phenotypes. 
5.2 Comparing Computable Phenotype Performance: Depression 
5.2.1 Comparing the Included ICD-10-CM Codes 
Executing the SPARQL queries specified in Chapter 4 allows for comparison between the set 
of ICD-10-CM codes included in the PheKB depression phenotype, versus the set of ICD-10-CM 
codes nested under the SNOMED concept “Depressive disorder.” HPO is mapped directly to 
SNOMED and includes the same codes—so, although SNOMED and HPO offer different user 
experiences, advantages, and disadvantages (detailed later in Chapter 6), they use the same codes 
for the phenotypes under investigation and are thus considered together in these results. Table 1 
breaks down the ICD-10-CM codes associated with depression from PheKB and SNOMED/HPO, 
respectively. 
 





ICD-10-CM code description PheKB SNOMED 
CT/ HPO* 
B94.9 Sequelae of unspecified infectious and parasitic disease  X 
F10.94 Alcohol use, unspecified with alcohol-induced mood 
disorder 
 X 






F13.94 Sedative, hypnotic or anxiolytic use, unspecified with 
sedative, hypnotic or anxiolytic-induced mood disorder 
 X 
F14.94 Cocaine use, unspecified with cocaine-induced mood 
disorder 
 X 
F15.94 Other stimulant use, unspecified with stimulant-induced 
mood disorder 
 X 
F16.94 Hallucinogen use, unspecified with hallucinogen-induced 
mood disorder 
 X 
F18.94 Inhalant use, unspecified with inhalant-induced mood 
disorder 
 X 
F19.988 Other psychoactive substance use, unspecified with other 
psychoactive substance-induced disorder 
 X 
F25.2 Schizoaffective disorder, depressive type  X 
F31.30 Bipolar disorder, current episode depressed, mild or 
moderate severity, unspecified 
 X 
F31.31 Bipolar disorder, current episode depressed, mild  X 
F31.32 Bipolar disorder, current episode depressed, moderate  X 
F31.5 Bipolar disorder, current episode depressed, severe, with 
psychotic features 
 X 
F31.76 Bipolar disorder, in full remission, most recent episode 
depressed 
 X 
F32.0 Major depressive disorder, single episode, mild X X 
F32.1 Major depressive disorder, single episode, moderate X X 
F32.2 Major depressive disorder, single episode, severe without 
psychotic features 
X X 
F32.3 Major depressive disorder, single episode, severe with 
psychotic features 
X X 
F32.4 Major depressive disorder, single episode, in partial 
remission 
X X 
F32.5 Major depressive disorder, single episode, in full 
remission 
X X 
F32.81 Premenstrual dysphoric disorder  X 
F32.89 Other specified depressive episodes X X 
F32.9 Major depressive disorder, single episode, unspecified X X 
F33.0 Major depressive disorder, recurrent, mild X X 
F33.1 Major depressive disorder, recurrent, moderate X X 
F33.2 Major depressive disorder, recurrent severe without 
psychotic features 
X X 
F33.3 Major depressive disorder, recurrent, severe with 
psychotic symptoms 
X X 
F33.40 Major depressive disorder, recurrent, in remission, 
unspecified 
X X 
F33.41 Major depressive disorder, recurrent, in partial remission X X 
F33.42 Major depressive disorder, recurrent, in full remission X X 
F33.8 Other recurrent depressive disorders X X 
F33.9 Major depressive disorder, recurrent, unspecified X X 
F34.1 Dysthymic disorder  X 




F43.21 Adjustment disorder with depressed mood X  
F53.0 Postpartum depression  X 
F91.8 Other conduct disorders  X 
G70.89 Other specified myoneural disorders  X 
O90.6 Postpartum mood disturbance  X 
O99.340 Other mental disorders complicating pregnancy, 
unspecified trimester 
 X 
O99.344 Other mental disorders complicating childbirth  X 
O99.345 Other mental disorders complicating the puerperium  X 
O99.89 Other specified diseases and conditions complicating 
pregnancy, childbirth and the puerperium 
 X 




*HPO cannot be directly mapped to ICD-10-CM; rather, HPO can be mapped to SNOMED CT, which 
is mapped to ICD-10-CM. Thus, the codes noted to be a part of the HPO hierarchy must first traverse 
through the SNOMED CT hierarchy. 
 
The PheKB phenotype offers the most opportunity to understand the reasoning behind the 
selected codes, as its authors provided the rationale for the choices they made in the phenotype’s 
documentation. As an example, the authors note that “Bipolar disorder may sometimes be 
misdiagnosed as major depression. Patients with bipolar disorder are not suitable as cases or 
controls in primary analyses for this phenotype...,”1 though they do flag whether patients found by 
their depression codes also have one or more bipolar codes. This is in contrast to SNOMED/HPO, 
which includes a subset of bipolar codes as child concepts (those that describe a “depressed 
episode”). This is an example of an ontological quandary, in that neither approach is incorrect—
rather, one approach may suit a particular study better than the other.  
In general, SNOMED/HPO is less specific and more sensitive than the PheKB phenotype. The 
SNOMED/HPO depression hierarchy includes every code in the PheKB list except for one (F43.21), 
but adds many others, including the aforementioned bipolar codes, drug-induced mood disorder 
codes, postpartum depression codes, and others. HPO actually maps the concept of depression to 
three different SNOMED concepts: 21061000119107 (“Mood disorder of depressed type 
(disorder)” [deprecated]), 35489007 (“Depressive Disorder”), and 78667006 (“Dysthymia”). The 




Because Dysthymia is a subclass of Depressive Disorder in SNOMED, it will already be captured in 
any mapping to Depressive Disorder and its subclasses. This explains why HPO and SNOMED map 
to identical ICD-10-CM codes for this particular phenotype. 
The increased sensitivity of the SNOMED/HPO phenotype may come at a cost, however, in 
that a few highly non-specific codes ended up in the SNOMED/HPO hierarchy, including T81.89X? 
(“Other complications of procedures”; note that this is an example of a code where mappers have 
inserted an “X?” as a placeholder, as discussed in Chapter 4) and B94.9 (“Sequelae of unspecified 
infectious and parasitic disease”). Querying the SNOMED graph reveals that T81.89X? is included in 
the hierarchy because “Postoperative Depression (Disorder)” (SNOMED:82218004) is mapped to 
T81.89X?—however, many other surgical complications are also mapped to this code (e.g., 
“Discharge from suture line (finding),” SNOMED:781185006). Likewise, B94.9 is a child concept of 
“Postviral depression (disorder),” which is itself a child of “Depressive disorder (disorder),” the 
original parent concept for this phenotype—but B94.9 is also mapped to 13 other conditions 
unrelated to depression. Such codes are so non-specific as to be not useful at best and misleading at 
worst. However, testing the true impact of these ill-fitting codes requires attempting to use them to 
identify a cohort. 
5.2.2 Comparing the Identified Patients 
Executing a query using these ICD-10-CM codes against a real-world patient dataset (in this 
case, the Opioid Triplestore) allows us to see the practical differences between PheKB and 
SNOMED/HPO when used for cohort identification. It should be noted that the cohort identification 
results shown here are valid for this patient set only (post-surgical patients prescribed at least one 
opioid); results may vary with other patient populations. However, as this patient set is not specific 
to any one condition, procedure, or medication, it is sufficiently general for this purpose. Table 2 
shows the results of comparing the populations identified in the Opioid Triplestore by the PheKB 




Table 2. Overlaps and differences between the cohorts defined by the PheKB and SNOMED/HPO 
depression queries against the Opioid Triplestore 
 
Query # patients 
found 
# patients found by 
this query only 
# patients found by 
both queries 
PheKB 1,739 35 1,704 
SNOMED/HPO 2,029 325 1,704 
 
The SNOMED/HPO phenotype clearly finds more patients, though it is not necessarily 
better—and notably, the SNOMED/HPO phenotype missed 35 patients identified by PheKB codes.  
It is important to consider which specific codes resulted in identifying patients in one 
cohort and not the other, which could either serve to pick up valid cases missed by the other 
phenotype, or to include false positives that the other phenotype manages to avoid. Examining 
Tables 3 and 4, none of the codes appear to fall into the latter category—rather, all could arguably 
have a place in a depression phenotype, depending entirely on the needs of a particular study. 





ICD-10-CM code description 
F25.2 Schizoaffective disorder, depressive type 
F31.30 Bipolar disorder, current episode depressed, mild or moderate severity, 
unspecified 
F31.31 Bipolar disorder, current episode depressed, mild 
F31.32 Bipolar disorder, current episode depressed, moderate 
F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features 
F32.81 Premenstrual dysphoric disorder 
F34.1 Dysthymic disorder 
F41.8 Other specified anxiety disorders 
F53.0 Postpartum depression 
O90.6 Postpartum mood disturbance 
O99.340 Other mental disorders complicating pregnancy, unspecified trimester 
O99.344 Other mental disorders complicating childbirth 
O99.345 Other mental disorders complicating the puerperium 
O99.89 Other specified diseases and conditions complicating pregnancy, childbirth 












ICD-10-CM code description 
F43.21 Adjustment disorder with depressed mood 
 
One of our highly non-specific codes, B94.9, did not match with any patients in the Opioid 
Triplestore, and therefore did not cause false positive cases in this particular cohort. However, 
T81.89X? (which does not appear in Table 3 for reasons explained below) presented a unique 
problem.   
As mentioned in Chapter 4, a complication occurs when a SNOMED code is mapped to an 
ICD-10-CM code that requires the seventh digit. Because the SNOMED concept does not account for 
the concept of an “encounter,” there is no accurate way to choose the proper seventh digit for the 
mapped ICD-10-CM code. In these cases, the mapping document replaces the seventh digit with a 
“?” and uses the placeholder “X” for non-required prior digits. Thus, when code-matching between 
SNOMED and ICD-10-CM, any maps that use the “?” or “X” characters will never exactly match with 
a code in the EHR. T81.89X? is one such code—there would never be a patient that would exactly 
match with the string “T81.89X,” which is not a valid ICD-10-CM code—and thus T81.89X? does not 
appear in Table 3.  
If we remove the “X?” and query the triplestore with a regular expression match to “T81.89” 
(to capture all variations on that code), we would add an additional 47 patients to the 
SNOMED/HPO cohort that would not have entered the cohort otherwise, and would not exist in the 
ICD-10-CM cohort. Due to the non-specificity of T81.89X?, these additional patients would be highly 
likely to be false positives—but this is beside the point. Though in the case of the depression 
phenotype, the unintentional exclusion of T81.89X? proved to be an advantage, this will not always 




mapped codes that use the “?” or “X” convention. A possible solution to this issue is addressed in 
Chapter 6. 
5.3 Comparing Computable Phenotype Performance: Rheumatoid Arthritis 
5.3.1 Comparing the Included ICD-10-CM Codes 
As with the depression phenotype, I started my analysis with a comparison of the ICD-10-
CM codes included in each of the phenotype sources for rheumatoid arthritis. Table 5 breaks down 
each codeset for comparison. 
 




ICD-10-CM code description PheKB SNOMED 
CT/ HPO* 
H20.10 Chronic iridocyclitis, unspecified eye  X 
M05*† Rheumatoid arthritis with rheumatoid factor X  
M05.00 Felty’s syndrome, unspecified site X X 
M05.20 Rheumatoid lung disease with rheumatoid arthritis, 
unspecified site 
X X 
M05.30 Rheumatoid vasculitis with rheumatoid arthritis, 
unspecified site 
X X 
M05.30 Rheumatoid heart disease with rheumatoid arthritis, 
unspecified site 
X X 
M05.60 Rheumatoid arthritis of unspecified site with 
involvement of other organs and systems 
X X 
M05.69 Rheumatoid arthritis of multiple sites with involvement 
of other organs and systems 
X X 
M05.819 Other rheumatoid arthritis with rheumatoid factor of 
unspecified shoulder 
X X 
M05.9 Rheumatoid arthritis with rheumatoid factor, 
unspecified 
X X 
M06*† Other rheumatoid arthritis X  
M06.049 Rheumatoid arthritis without rheumatoid factor, 
unspecified hand 
X X 
M06.079 Rheumatoid arthritis without rheumatoid factor, 
unspecified ankle and foot 
X X 
M06.80 Other specified rheumatoid arthritis, unspecified site X X 
M06.821 Other specified rheumatoid arthritis, right elbow X X 
M06.822 Other specified rheumatoid arthritis, left elbow X X 
M06.831 Other specified rheumatoid arthritis, right wrist X X 
M06.832 Other specified rheumatoid arthritis, left wrist X X 
M06.839 Other specified rheumatoid arthritis, unspecified wrist X X 




M06.842 Other specified rheumatoid arthritis, left hand X X 
M06.851 Other specified rheumatoid arthritis, right hip X X 
M06.852 Other specified rheumatoid arthritis, left hip X X 
M06.861 Other specified rheumatoid arthritis, right knee X X 
M06.862 Other specified rheumatoid arthritis, left knee X X 
M06.871 Other specified rheumatoid arthritis, right ankle and foot X X 
M06.872 Other specified rheumatoid arthritis, left ankle and foot X X 
M06.879 Other specified rheumatoid arthritis, unspecified ankle 
and foot 
X X 
M06.9 Rheumatoid arthritis, unspecified X X 
M25.80 Other specified joint disorders, unspecified joint  X 
 
†The PheKB phenotype includes every possible ICD-10-CM code beginning with “M05” or “M06.” As 
listing every code in this table would impact readability, this table primarily illustrates that 
SNOMED/HPO only uses a subset of the codes in the M05/M06 range. Any code in that range not 
listed in the table should be assumed to not be included in SNOMED (but is included in the PheKB 




Interestingly, the SNOMED/HPO-derived list of codes appears to be missing a fair number of 
the codes in the M05* and M06* hierarchies. As just one example, in the M05 range, there are 
specific codes included in SNOMED/HPO for RA in hands and shoulders, but not knees, wrists, hips, 
or ankles. One possible reason for this could have been the pre-processing step that removed any 
context-dependent mappings from the SNOMED-to-ICD-10-CM mapping file. If there were no non-
context-dependent mappings that used the same code, there is a potential that one or more of the 
codes in that range could have been removed from the ontology completely, and would therefore be 
unavailable for searching. However, a manual check of all codes in the M05* and M06* ranges 
showed that no codes were removed for this reason, eliminating this potential issue as a source of 
the code discrepancy. 
Another potential cause of missing codes is when the subClassOf relationship in the 
ontology does not nest concepts in the way we might expect. As an example, in SNOMED, 
“Seronegative rheumatoid arthritis (disorder)” maps to ICD-10-CM M06.041—yet that code is 
missing from Table 5, and therefore is missing from the codes used in the phenotype. After 




rheumatoid arthritis (SNOMED: 239792003) is not nested underneath Rheumatoid arthritis 
(SNOMED: 69896004). These two concepts do share a parent concept (Autoimmune disease), but 
have no other connection to each other. As can be seen in Figure 1, “Autoimmune disease” is far too 
broad a concept to incorporate into this phenotype just to capture these two disconnected 
concepts.  
 
Figure 1. Rheumatoid arthritis (top left) and Seronegative rheumatoid arthritis (bottom left) share 
a parent of Autoimmune disease (at the center of the cluster), but are not otherwise connected. 
Autoimmune disease has too many unrelated child concepts (the cluster) to be useful in the RA 
phenotype.  
 
At present, there is not a good ontology-based solution to this issue other than changing the 
ontology to add a parent-child relationship where there is currently not one. In order to better 




International Health Terminology Standards Development Organisation (IHTSDO, owners of 
SNOMED CT). To my surprise, they accepted my suggested change (to add a parent-child 
relationship between those concepts) and remodeled the ontology accordingly. The change will be 
reflected in the July 2020 International Release of SNOMED. I have included a copy of my 
correspondence with IHTSDO (with names and email addresses removed) as Appendix 5.1. Notably, 
Campbell et al. had a similar experience suggesting a correction to IHTSDO when they modeled and 
tested SNOMED as a graph, suggesting that this is not an isolated incident, and that researcher-
offered corrections are an important part of SNOMED quality assurance.2 
In addition to differences in the M05 and M06 code ranges, there are two codes outside of 
those ranges included in SNOMED/HPO that are not included in the PheKB phenotype: one for 
chronic iridocyclitis, and the other for “other specified joint disorders.” The former, an 
inflammation of the iris, may seem out of place—however, its child-parent relationship to RA in 
SNOMED is shown in Figure 2. The latter’s inclusion may seem more intuitive, though it is a much 
broader concept than rheumatoid arthritis. A use case requiring a highly specific phenotype for RA 
may not want to include a “catch-all” code like this in the interest of avoiding false positives. As with 
the depression phenotype, these extra codes cannot be seen as necessarily valid or invalid 






Figure 2. Illustration of the relationship between ICD-10-CM code H20.10 (chronic iridocyclitis) 
and the parent SNOMED CT rheumatoid arthritis concept. Interestingly, the same concept maps to 
M06.80, “Other specified rheumatoid arthritis, unspecified site.” 
 
5.3.2 Comparing the Identified Patients 
As with the depression phenotype, the true discrepancies between the SNOMED/HPO and 
PheKB phenotypes for rheumatoid arthritis are best shown when using them to identify a cohort. 
Table 6 shows the cohort identification results for the PheKB and SNOMED/HPO phenotypes, 
queried within the Opioid Triplestore. Tables 7 and 8 list the codes that matched Opioid Triplestore 
patients in one codeset but not the other. 
Table 6. Overlaps and differences between the cohorts defined by the PheKB and SNOMED/HPO 
queries 
 
Query # patients 
found 
# patients found by 
this query only 
# patients found by 
both queries 
PheKB 166 30 136 












ICD-10-CM code description 
M25.80 Other specified joint disorders, unspecified joint 
 





ICD-10-CM code description 
M06.00 Rheumatoid arthritis without rheumatoid factor, unspecified site 
M06.031 Rheumatoid arthritis without rheumatoid factor, right wrist 
M06.032 Rheumatoid arthritis without rheumatoid factor, left wrist 
M06.041 Rheumatoid arthritis without rheumatoid factor, right hand 
M06.042 Rheumatoid arthritis without rheumatoid factor, left hand 
M06.09 Rheumatoid arthritis without rheumatoid factor, multiple sites 
M06.4 Inflammatory polyarthropathy 
M06.869 Other specified rheumatoid arthritis, unspecified knee 
M06.89 Other specified rheumatoid arthritis, multiple sites 
 
Unlike the depression phenotype, where most of the differences between the codesets are 
somewhat subjective, the SNOMED/HPO RA codeset seems to be simply missing several objectively 
necessary codes. Of the codes in Table 8, the first six (M06.00 through M06.09) will actually be fixed 
in the July 2020 release of SNOMED, which will incorporate the change I requested. The last three 
codes, M06.4, M06.869, and M06.89, are not represented anywhere in the ICD-10-CM to SNOMED 
mapping (context dependent or otherwise). Unless and until these missing codes are added to 
SNOMED, it would be hard to recommend use of SNOMED or HPO for an RA phenotype over and 











6.1 Primary Findings 
In this work, I proposed and tested a new computable phenotyping methodological 
framework based on semantic web technologies, and hypothesized that this methodology can begin 
to address the critical issues of semantic ambiguity and lack of interoperability in the practice of 
computable phenotyping. The results of this work show that this method indeed holds promise, but 
may be difficult to implement in general practice until critical vocabularies are more mature. 
However, the results are encouraging enough for this method to (1) be put in practice in 
combination with other, more common phenotyping methods or (2) be used on its own for 
particularly well-suited use cases. 
6.2 Application of Findings 
6.2.1 Research Question 1: Can clinical ontologies (specifically SNOMED CT and the Human 
Phenotype Ontology) offer a less semantically ambiguous mechanism to perform computable 
phenotyping than reimbursement-focused terminologies (specifically ICD-10-CM)? 
 
6.2.1.1 Ontologies as a Possible Answer 
As discussed in Chapter 1, ICD-10-CM is a reimbursement-focused terminology in the US, 
used as much for capturing charges during the course of care as for disease classification and 
categorization. As shown in Chapter 1’s Figure 2, when this dual purpose is combined with human 
error and faulty assumptions, using ICD-10-CM in a computable phenotype can easily miss patients 
who should otherwise qualify for a cohort, or falsely identify patients who should be excluded.   
More subjectively, ICD-10-CM’s focus on coding for administrative purposes can also make 




example of this challenge is a very current one: coding for COVID-19. The ICD-10-CM standard does 
not have the capacity to make significant changes quickly—but, because COVID-19 is a rapidly 
emerging new disease, there was an urgent need for guidance on how to use existing ICD-10-CM 
codes in this new context. Thus, in their April 1, 2020 coding guidance, the CDC stated that 
screening for COVID-19 should be coded as  Z11.59, Encounter for screening for other viral 
diseases.1 This code is now in heavy use across the US; however, for a downstream researcher, this 
code presents two major problems:  
 
1. Z11.59 was used for many other types of viral screenings prior to COVID-19 (e.g., hepatitis 
screenings), meaning that searching for all patients with that code in an EHR will result in 
false matches. 
2. The description associated with this code is generic and non-specific, making it difficult to 
find without delving deep into coding guidance.  
 
Defining a patient screened for COVID-19 using the EHR, then, is rife with semantic ambiguity.  
Despite these flaws in its application, ICD-10-CM does serve an important purpose, and it is 
unlikely for EHRs to discontinue its use. One possible improvement would be to reorganize ICD-10-
CM into a more logical hierarchy, where a user can easily access not only the most “obvious” code 
for their condition of interest (i.e., the first search result on Google, or a list of codes used in a prior 
study’s phenotype), but also a selection of other possibilities from elsewhere in the hierarchy. As 
such a reorganization is unlikely, ontologies like SNOMED and HPO offer a possible alternative, as 
shown in my results.  
To illustrate the contrast between using SNOMED/HPO and ICD-10-CM in a computable 
phenotype, let us return to the depression use case. If a researcher knows they want to exclude 






 A Google search for “icd-10 depression” has a first result of F33* (“Major depressive 
disorder, recurrent”). A slightly deeper dive into the ICD-10-CM hierarchy might lead the 
same researcher to also choose F32*, Major depressive disorder, single episode. 
 The PheKB phenotype for depression goes just a bit outside this range, as shown in Chapter 
5, including F43.21 (“Adjustment disorder with depressed mood”). 
 Using SNOMED or HPO offers far more options, including conditions like postpartum 
depression, drug-induced depression, and bipolar disorder, but also includes some potential 
red herrings. 
 
Three different methods, three different definitions of depression. As illustrated in Figure 1, 
while it may not be possible to resolve the semantic ambiguity inherent in these different 
definitions, ensuring that all of the different definitions are captured in our final codeset will 
provide the greatest chance of capturing all intended meanings, and thus identifying as many 
qualifying patients as possible.  
 
Figure 1. Searching for diabetes patients using exact ICD-10-CM code matches (left) versus using 
ontology concepts and their descendants (right). 
 
It is arguable that the “menu” with the most choices (the ontology-driven menu) might be 
best for the researcher who is non-expert in depression, even if many of the items on that menu go 




share the list with colleagues who are more expert in the condition, or do additional independent 
research on which codes to include or exclude from the final list. This process of picking and 
choosing is less possible with the narrower, targeted code lists generated by the other methods. 
This effectively puts the burden of resolving the semantic ambiguity squarely on the researcher; 
however, this added effort is likely more desirable (and more thorough) than glossing over the 
ambiguity entirely. 
In a well-cited 2017 paper, Wei et al. recognized the shortcomings of ICD codes (ICD-9-CM 
codes, in their case) in providing logical groupings of codes for use in EHR phenotyping. However, 
rather than turn to an existing medical terminology like SNOMED, they devised their own groupings 
of ICD-9-CM codes into more phenotyping-friendly categories called “phecodes” (for example, 
grouping together the codes for lung cancer [162.X] and history of lung cancer [V10.1], which are 
normally in separate areas of the ICD-9-CM hierarchy).2 In doing so, the authors in effect replicated 
a key function of SNOMED. In their validation study, Wei et al. found that their phecodes were 
significantly more effective at accurately identifying patient cohorts from EHRs when compared to 
ICD-9-CM codes. This finding adds credence to the idea that ICD codes are not ideal phenotyping 
tools absent the imposition of more phenotype-oriented groupings. Based on the results of the 
current study, however, I would suggest that it is more efficient, transparent, sustainable, and 
reproducible to use a well-maintained ontology’s hierarchy to define these groupings rather than 
manually grouping codes. There are two main caveats to this approach, however, as can be seen in 
my results. 
 
Caveat #1: Non-specific and missing codes. In both of the experiments detailed in Chapters 4 and 
5, the ontology-based codeset included a few non-specific, “red herring” codes that could present 
problems if used to define a cohort. Some of these codes dropped out when actually used to query 
patient data in the Opioid Triplestore, but some remained (e.g., O99.89 [“Other specified diseases 




The extent to which this issue would affect the downstream cohort identified using these codes 
could vary significantly depending on the condition of interest.  
The opposite problem also occurs, where potentially important codes are missing from the 
ontology-based codesets. For the depression cohort, the effect was not considerable—however, the 
rheumatoid arthritis codeset was missing several critical codes in the M06 range, due to the (soon 
to be corrected) flaw in the SNOMED ontology.  
It is likely that many more such errors and omissions exist in the SNOMED ontology, with 
the potential to cause the same issue for other conditions. Ironically, though SNOMED’s use of 
description logics allows it to build and maintain its sizable, complex hierarchy, those same 
description logics (and the automated processes that apply them) can be the cause of significant 
quality issues. Rector, et al. note SNOMED’s use of description logics can cause incorrect 
information to propagate across the hierarchy, far from the original source of the error, as well as 
make it difficult to correct errors—if errors are not corrected at the “root” of the problem, the error 
will be made again each time the classifier is run.3 Their paper found several serious errors in the 
SNOMED hierarchy (including locating the dorsalis pedis artery, found in feet, in the pelvis). 
Notably, however, this and other errors identified by Rector, et al. have been corrected in later 
versions of SNOMED. This does suggest that SNOMED (and, by extension, other prominent 
ontologies) improve with age and feedback.  
If we accept that ontology-based phenotyping will often result in either excess concepts or 
missing concepts in a phenotype, we must devise compensating controls for those issues before the 
method is a viable option. For excess codes, manual culling is likely the best approach. Once a 
researcher is presented with the possible list of codes, it is almost certain that some degree of 
editing will be necessary. Some edits will be obvious—others may require a second look, or 




One particularly vexing problem, as we saw in Chapter 5, is specific to the official SNOMED 
to ICD-10-CM mapping—the convention of using “?” as a placeholder in ICD-10-CM codes that 
require the seventh digit. This convention caused 47 patients to drop out of the depression 
cohort—patients that would have been picked up by various codes in the T81.89 range. As noted in 
Chapter 5, these patients would have been likely false positives for the depression use case—
however, it is just as likely that patients dropped for this reason would be true cases in another 
cohort. Thus, when using SNOMED to ICD-10-CM mapping, it is critical to watch for codes in the 
ontology path of interest that contain the “?.” It is not enough to simply drop the question marks, as 
they are often preceded by placeholder “Xs” that are equally meaningless, and vary in number. One 
cannot simply drop all Xs either, as “X” is a valid character in many ICD-10-CM codes. Thus, in order 
to deal with this issue (which, again, is specific to the SNOMED to ICD-10-CM map, not ontologies in 
general), it is necessary for the user to critically examine the full list of codes that will be used in a 
SNOMED query to determine whether any of the codes include the “?” convention. If they do, those 
code(s) can be manually re-added to the SPARQL query as regular expression matches running in 
parallel with the ontology-traversing query. 
The issue of missing codes is tougher, particularly when the cause of the missing codes is a 
flaw in the ontology. It would seem that the safest option in this case would be to cross-reference 
the list of ontology-generated codes with other sources (PheKB, other published phenotypes, 
searching the ICD-10-CM hierarchy directly, etc.). This method fits with my assertion that ontology-
driven code selection, at least at this time, should not be the only method of code selection, but that 
it is well suited to augment other methods (which each have their own caveats to consider). 
 
Caveat #2: The triplestore requirement. As noted in Chapter 2, a triplestore is the ideal 
technology to integrate data and ontologies such that they can be queried in the ways illustrated in 




nowhere near as common as relational databases. Perhaps more daunting is the triplestore’s large 
space requirements when populated with patient data, as shown in Chapter 3.  
One way to address this issue would be to institute a practice whereby the ontologies are 
stored and queried in a triplestore, but the patient data are not. This would enable the researcher 
(or an informatician colleague) to use the capabilities of the triplestore to find the appropriate code 
list, which could then be used to query a more standard relational database of patient data to 
actually identify the cohort. The disadvantage of this approach is that it does not achieve the 
interoperability benefits that triplestores present, discussed in more detail in the next section. 
Based on the experience gained during the construction of the Opioid Triplestore, I might 
also suggest limiting the use of triplestores to data on individual patient cohorts, rather than 
attempting to translate an institution’s entire clinical data warehouse into triples. As discussed in 
Chapter 2, it is not possible to determine the “best” NoSQL technology in a vacuum—rather, the 
judgment must be based on a particular use case. It may not be that every computable phenotyping 
exercise demands a triplestore or ontological approach. It seems fair, however, to offer the option 
to those use cases that would benefit. 
6.2.1.2 SNOMED CT versus the Human Phenotype Ontology 
In this study, I examined the potential of both SNOMED CT and the Human Phenotype 
Ontology (HPO) as computable phenotyping tools. In Chapter 5, HPO’s utility is somewhat hidden, 
as HPO maps directly to SNOMED (and thus shares the same query results). However, HPO does 
have important differences from SNOMED that go beyond the codes mapped within it. These 
differences make it well worth discussing HPO as a separate ontological tool than SNOMED that 
may better serve certain use cases. 
 Unlike SNOMED, HPO bridges the gap between genome biology and clinical data.4 
Additionally, HPO includes many “hooks” to other prominent ontologies such as Orphanet (rare 




the scope of this study, these hooks could enable computable phenotyping from entirely different 
angles than are possible with SNOMED, or any exclusively clinical ontology. With HPO, phenotyping 
queries can be centered on genes and mutations, or even symptoms and traits that are often not 
coded in EHRs (e.g., “smooth swollen tongue,” “joint hypermobility,” etc.). An illustration of this 
potential is shown in Figure 2. 
If HPO is integrated into a clinical data repository in the manner demonstrated in this 
study, the kinds of cross-ontology links illustrated in Figure 2 would allow a user to execute queries 
like: 
 Identify all patients with a disease associated with changes in gene HLA-DRB1. 
 Identify all patients with diseases that may cause skin plaques. 
 Identify all patients with diseases that can result in blindness. 
 
None of these questions are possible to answer using clinical ontologies alone (and certainly not 
ICD-10-CM), demonstrating why broader ontologies like HPO have such enormous potential when 





Figure 2. In this screenshot from the HPO browser (https://hpo.jax.org/app/browse/term/ 
HP:0001370), links in the ontology allow the user to “walk” from the concept of rheumatoid 
arthritis to genes associated with that condition. From there, the user can see other diseases 
associated with those same genes. 
 
6.2.1.3 Recommendations 
If the caveats are known, considered, and adjusted for, based on the results of this study I 
would not hesitate to recommend that a researcher building a computable phenotype consider a 
union of the codes from (1) a quick search of the ICD-10-CM hierarchy, (2) the corresponding 
PheKB phenotype, if available, or other published phenotype definition, and (3) the codeset defined 
by querying the SNOMED or HPO graph. This codeset would represent a curated-yet-broad set of 
choices that could be manually culled by the researcher in order to define their cohort for the needs 
of their use case. Semantic ambiguity may have affected the decisions of which codes to apply to 
patients during the course of care, but casting a wide net using ontologies could ensure that that 




6.2.2 Research Question 2: Does the use of semantic web technologies and standards (e.g., 
Resource Description Framework (RDF), triplestores, the Web Ontology Language) in tandem 
with ontologies improve the interoperability prospects of computable phenotypes and the 
underlying clinical data? 
 
6.2.2.1 Interoperability Advantages of the Triplestore/FHIR/Ontology Architecture 
The architecture constructed for this study relies on three components that lend themselves to 
interoperability: 
 
 RDF and Blazegraph, both open-source, semantic web technologies that are purpose-built 
for data exchange 
 HL7 FHIR, which is on its way to becoming the de facto standard for healthcare data 
exchange 
 Established ontologies (here, SNOMED and HPO), whose goals are to describe clinical and 
clinically relevant concepts in a standard way 
 
The pipeline used to create the architecture for this study is itself available as fully 
documented open-source software, and is designed to be used with minimal local changes to 
construct interoperable datamarts. 
Consider a scenario in which another healthcare institution wishes to join the Opioid 
Triplestore project, and uses the pipeline to create a triplestore at their site similar to the one 
housed at UNC. Doing so would address some of the interoperability roadblocks that frequently 
affect data-driven, multi-institutional research. To illustrate this, we can use the categories from 
Benson and Grieve’s interoperability framework, introduced in Chapter 1. 
Interoperability Challenge #1: Inconsistent data models 
Benson/Grieve Interoperability Category: Technical 
Addressed By: FHIR, RDF 
 
The proliferation of common data models (CDMs, such as i2b2, PCORnet, and OMOP) for 
EHR data has had a positive impact on cross-institutional data sharing. However, there is no 




potentially negating the advantage. As discussed in Chapter 3, FHIR may help to address this by 
serving as a “meta-CDM” to bring them all together—and because FHIR is becoming an operational 
standard, getting data into FHIR format may not require the complex extract – transform – load 
work that is required when building other CDMs. Rather, FHIR can be exported directly from the 
EHR.  
FHIR’s serialized format does not make for easy querying, but this can be overcome by 
using the pipeline to transform the FHIR data into RDF and load it in a triplestore. In this way, the 
triplestore is serving as a convenient mechanism to access and analyze serialized data. Moreover, 
consistent triple structures at each site ensure that a SPARQL query run at one site can be shared 
with and run by the other, with minimal (if any) changes.  
Interoperability Challenge #2: Differing ICD-10-CM coding practices 
Benson/Grieve Interoperability Category: Semantic 
Addressed By: Ontologies 
 
Using ontologies to “roll up” lower-level codes, as is possible using this architecture, can 
make differing coding practices among healthcare institutions less consequential, so long as the 
caveats previously discussed are considered. Returning to the COVID-19 example, if one institution 
tends to code all COVID-19 screenings with Z11.59, and a second institution uses Z11.59 only for 
asymptomatic screenings, and Z20.828 for symptomatic screenings, these differences become moot 
if both codes are nested under the SNOMED CT code for COVID-19, 840539006. Querying using the 
nested concepts in ontological hierarchies is possible using relational databases, but is challenging 
from a data modeling perspective. In contrast, SPARQL natively excels in this space. 
Interoperability Challenge #3: Lack of Interoperability with Non-EHR Data 
Benson/Grieve Interoperability Category: Technical, Semantic 
Addressed By: RDF 
 
As was demonstrated in Chapter 3, EHR data may not only need to interoperate with other 
EHR data, but also with other relevant, non-clinically derived datasets in order to answer certain 




not, the pipeline constructed for this study offers a transformation module to convert CSV datasets 
to RDF or OWL as needed. Once in RDF, assuming best modeling practices are followed, the dataset 
should be able to interoperate with any number of clinical datasets transformed by the same 
pipeline. 
6.2.2.2 Caveats for this Architecture 
As mentioned above, triplestores are not without disadvantages. In addition to their large 
size, triplestores come with a learning curve; RDF and SPARQL are nowhere near as common as 
CSV files and SQL. Though the pipeline constructed for this study attempts to provide shortcuts for 
some of the more obscure steps in the process (e.g., converting FHIR to RDF), an institution would 
still need to feel generally comfortable with the technology in order to move forward with such an 
architecture. This is compounded by the fact that in order to truly realize the interoperability 
benefits offered by semantic web technologies, it would be ideal for multiple institutions to 
participate. For this to happen, the benefits of this architecture would clearly need to outweigh the 
resource expenditure and any perceived risks. 
It is also worth noting that this architecture does not address two of Benson’s and Grieve’s 
interoperability categories: process and clinical. These two aspects of interoperability are critical, 
but as they are highly dependent on the human users of healthcare technology, they are not likely to 
be addressed by a technology solution alone.  
6.2.2.3 Recommendations 
The opportunities presented by triplestores (in tandem with RDF and FHIR) for ontology 
integration and interoperability may offset the relative complexity of implementation for certain 





 Multi-site clinical studies in which all participating institutions do not share a common data 
model; 
 Studies whose research questions would benefit from integration with a broadly linked 
ontology like HPO, or to several external (i.e., non-EHR) datasets; 
 Studies requiring highly sensitive phenotypes, with less emphasis on specificity; 
 Studies whose phenotypes are based on broad disease definitions that encompass a wide 
spectrum of ICD-10-CM codes, such as “chronic pain,” “mobility issues,” or “rare diseases”; 
 Studies whose phenotypes rely heavily on the relationships between concepts (e.g., 
“identify all patients taking drugs that have an adverse interaction with acetaminophen”). 
 
 It would not be true to say that the above use cases would not be possible to execute using 
the relational model—there are certainly modeling workarounds that could accommodate these 
needs. However, as shown in Chapter 2, choosing the appropriate NoSQL technology for certain use 
cases may present performance and functionality benefits over forcing the use of the relational 
model. When choosing triples over relations (and SPARQL over SQL), the user enables complex data 
linkage, ontology integration, relationship-heavy querying, and reasoning and interference. 
6.3 Why offer multiple phenotyping methods?  
The current study focused on applying ontologies to diagnosis codes, but there are many 
other codesets that can be used in computable phenotyping (e.g., LOINC, RxNorm, CPT, etc.) that 
may also be linked with ontologies with equal (or more) efficacy. Zhang, et al. have attempted to do 
just this, in fact, by creating ontology cross-references between LOINC-encoded lab test results and 
HPO.5 As an example of how this could be applied in computable phenotyping, imagine needing to 
identify a cohort with diabetes, and having access to a data point showing that a patient has an 
HbA1c result of 7.8%. This is a fact represented at the data level. Knowing that that value might be 




that can be accomplished by simply having that knowledge a priori, or, alternatively, by using 
ontologies (where an abnormal HbA1c result is a child concept of the parent “diabetes mellitus”)—
even if the user looking for patients with diabetes never thinks to ask about HbA1c.  
Consider also medications, where a single mediation can be coded with any one of several 
(hundreds, possibly) RxNorm codes. It is generally unreasonable to expect a researcher to compile 
every possible code for a list of medications, especially if the list of interest is lengthy. However, 
these codes must be gathered in full in order to ensure that qualifying patients aren’t missed. Exact 
code matching isn’t the only option, however—ontologies and OWL reasoning capabilities can help 
here.6–8 With appropriate ontologies and OWL reasoning one can, for example, use logic to 
determine that a patient taking escitalopram should be retrieved in a query requesting all patients 
using selective serotonin reuptake inhibitors, as well as a query requesting all patients using anti-
depressants, without the patient needing to be directly linked to the latter two categories (and 
without the user executing the query needing to know the specific drug name). Aggregating 
individual medications up to a more “common sense” parent category is a strength of ontologies, 
and is thus a very worthwhile phenotyping method to offer to researchers. 
In general, as data at the knowledge level is not often stored in the EHR itself, the ability to 
link to ontologies containing that knowledge adds richness to a clinical data store; querying a data 
store using higher-level concepts may also be more intuitive.9–11 In their ideal form, ontologies 
allow users to make connections to data that can answer questions the user never thought to ask. 
6.4 Need for consistent, mature, ontologies 
As discussed earlier, one of the roadblocks to implementing ontology-based phenotyping in a 
“production” capacity at this time is the varying quality of ontologies. A continual need for 
resources (time, funding) is a barrier to the ongoing maintenance and development of medical 
terminologies and ontologies. The sheer number of life sciences ontologies available on the Linked 




scholars and ontologists to create new terminology resources—what is less clear is how well-
maintained those resources are. Kamdar, et al. note additional challenges that may prevent 
widespread use of these resources: 
 
 A lack of awareness among researchers as to what resources exist and where; 
 The requirement of sizeable compute resources and programming skills in order to use 
large ontologies; and 
 The need to enable the consumption of resources in heterogeneous formats and syntaxes.12  
 
Many of these challenges are inherent in open-source communities (at least open-source 
communities in early stages of their existence)—a Wild West, where adherence to standards, 
continual development, and regular maintenance are at the sole discretion of the resource’s creator. 
However, particularly for biomedical research, these challenges do not only make terminology 
resources potentially difficult to use, but also bring into question the trustworthiness of the 
resources themselves. There is a gravitas inherent in terminologies like ICD-10-CM (published and 
maintained by the World Health Organization), SNOMED (the International Health Terminology 
Standards Organization), and LOINC (the Regenstrief Institute), and others, as each are “owned” 
and maintained by well-known, established organizations that put the weight of their reputation 
behind their ontologies and terminologies. Smaller resources owned and maintained by individual 
research groups may be equally valuable, and equally trustworthy as their larger, more 
recognizable peers. But, they are also more likely to be abandoned once maintainers run out of 
funding or leave the project. 
Another challenge with terminologies on the Linked Open Data Cloud is a more practical 
one, specifically relating to the use of RDF as a lingua franca. There is an assumption in the semantic 
web community that publishers of RDF graphs will reuse uniform URIs wherever possible to label 




where it makes sense (e.g., my use of skos:closeMatch to link ICD-10-CM and SNOMED URIs in this 
study). This ideal would make it seamless to hop from one terminology to another—a true 
biomedical semantic web. In reality, however, achieving this ideal depends on individual 
contributors following the rules, which does not always happen in an open community. HPO, used 
in this study, is a perfect example. If you reference the SPARQL query in Box 4 in Chapter 4, it 
becomes apparent that HPO does not use best practices to map entities from one ontology to 
another. If it followed the ideal, the HPO code for “Depression” would map to its equivalent 
SNOMED code as such: 
 
PREFIX hpo: <http://purl.obolibrary.org/obo/> 
PREFIX oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> 
PREFIX snomed: <http://snomed.info/id/> 
 
hpo:HP_0000716 oboInOwl:hasDbXref snomed:35489007 . 
 
 
In this code, the URI for Depression in HPO (http://purl.obolibrary.org/obo/ 
HP_0000716) is directly mapped to the URI for Depression in SNOMED (http://snomed.info/id/ 
35489007). A query against either ontology could easily become a query against both ontologies. 
However (and unfortunately), this is not how HPO actually works. Instead, HPO uses custom, “local” 
URIs for SNOMED codes (and other database cross-references). Rather than referencing Depression 
in SNOMED by its SNOMED URI, HPO uses http://purl.obolibrary.org/obo/SNOMEDCT_US: 
35489007. This requires the user to manually construct proper URIs via string matching (as shown 
in Chapter 4, Box 4) to replicate the logic in the “ideal” query above. Because it does not follow best 
practices, HPO limits researchers’ ability to make use of the very affordances of the semantic web 
that RDF and OWL seek to encourage. (And, moreover, this practice degrades query performance 
due to the need to use a computationally expensive string match operation.) 
Kamdar et al. use the example of a very successful ontology, the Gene Ontology (GO), as a 





1. A dedicated development team with continuous funding; 
2. A highly engaged user community whose priorities dictate development priorities; 
3. Excellent documentation; 
4. Clear development principles that are actually followed; and 
5. Automated quality checking routines.12 
 
Certainly, some of these factors are not entirely within the control of an ontology’s 
developers (continuous funding, for example)—however, GO’s success should not be seen as an 
unachievable by others. Following points 3 through 5 above would go a long way to ensure that an 
ontology is of high quality, even it is ultimately abandoned. Following those principles would also 
allow new developers to pick up where the originators leave off, if the domain of the ontology is 
determined to be of high importance to its user community. 
Another potential method to improve biomedical ontology maturity is for health care 
organizations to make use of them outside of the research context. If, for example, physicians were 
able to easily “tag” patients with concepts from the HPO within their daily EHR workflow (e.g., 
tagging a pediatric patient with abnormally long fingers with the corresponding HPO concept 
HP:0100807 [“Long fingers”]), more structured information could be gathered about patients 
outside of the context of a diagnosis or billable procedure. The HPO may provide utility for 
physicians, who lack a controlled vocabulary in the EHR to describe things about patients that 
aren’t “diseases,” but may have implications for their health all the same. This would be a benefit for 
physicians and clinical researchers alike, but would also be beneficial to the health of the ontology 
itself. With wide, high-stakes use in the EHR workflow, there would be more motivation (and likely 
more financial resources) to keep HPO fresh, well-documented, and high-quality. Starting to use 
ontologies like SNOMED and HPO in computable phenotyping to augment current methods could 
have a similar effect—with more active use, there are more users to catch and fix errors, add 





In addition to the various caveats already discussed, there are a few additional limitations of 
this work. One of these is a limitation of EHRs themselves, which ask physicians to assign diagnosis 
codes to patients using ICD-10-CM codes. This means that the only structured diagnosis data 
available for patients in the EHR is encoded using a system that has been shown to be imperfect for 
phenotyping (ICD-10-CM). Thus, even if SNOMED or HPO were inarguably perfect phenotyping 
systems, if the only way to attach SNOMED or HPO codes to patients is to map through pre-assigned 
ICD-10-CM codes (as was the case with this study), we are passing on much of the imperfection of 
ICD-10-CM coding to the SNOMED and HPO codes. As this reliance on ICD-10-CM is an artifact of the 
US healthcare system, there are really no workarounds for this limitation—it must simply be 
acknowledged.  
Additionally, Kamdar et al. state that publishers of terminologies and ontologies often 
mention their resource’s “potential” to solve data integration challenges, but only demonstrate their 
use in highly controlled, limited experiments.12 That statement applies in many ways to the current 
study as well, revealing a limitation of testing whether linked open data can be used to improve 
computable phenotyping in general: what works well for one phenotype may fail for another, for 
inconsistent reasons. This was shown very clearly by the markedly different performance of the 
SNOMED and HPO ontologies in the depression phenotype versus the rheumatoid arthritis 
phenotype. I suspect that testing additional phenotypes would result in similarly wide variation. 
For this reason, as stated earlier, I would suggest ontology-based phenotyping as an augmentation 
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VII. CONCLUSION AND FUTURE WORK 
7.1 Introduction 
The computable phenotyping status quo, where lengthy lists of codes are exactly matched 
with concepts tagged in the EHR, does not align with the way that users of computable phenotypes 
think of their cohorts. Though ICD-10-CM’s hierarchy does have a system of organization (shown in 
Figure 1), many perfectly reasonable cohort definition criteria don’t fit cleanly. Anyone interested 
in patients with “genetic disorders,” “chronic pain,”  or “adverse reactions to antibiotics,” just to 
name a few examples, will find themselves picking through large chunks of the ICD-10-CM 
hierarchy to collect all the relevant codes—or quitting in frustration at the prospect of such a 
formidable task. 




As we saw in Chapters 4 through 6, ontologies (specifically SNOMED and HPO) are more 
flexible in their organization. A single concept can have multiple parents (and siblings, and 
children) and can thus be reached from many paths. With less rigidity, an ontology is closer to the 
“natural” way humans tend to categorize the world around them. They are less semantically 
ambiguous than reimbursement-focused codesets, and as such also promote interoperability. Yet 
we also saw that ontologies have their own issues that prevent them from serving as a total 
replacement for exact code matching in computable phenotyping. Thus, if both the status quo and 
the suggested alternative are imperfect, it seems that a hybrid solution is in order. 
7.2 A New Way to Present Codesets for Phenotyping 
For nearly a decade, I have been supporting researchers to execute computable phenotypes 
against EHR data—and, with increasing frequency, to share those phenotypes with external 
collaborators. Some investigators come in knowing exactly what codes they’re looking for (or are 
looking to exclude); most, however, do not, especially if some of their cohort criteria are intended to 
identify conditions in which they are not an expert. Researchers in the latter category usually resort 
to Googling the right codes to use—and depending on their level of thoroughness (and perhaps 
patience), the resulting list of codes will vary wildly in quality and coverage. Ideally, as proposed in 
Chapter 6, a hybrid solution between picking through the ICD-10-CM hierarchy and ontology-
derived codesets would allow investigators to explore on their own, selecting codes for their 
phenotype from a superset of the options.  
 There currently exists some electronic tooling to support this kind of work, though the 
available options are non-ideal. Putting a clinical investigator in front of the online SNOMED 
browser (https://browser.ihtsdotools.org/?) or HPO browser (https://hpo.jax.org/app/) would 
not be much of an improvement over the ICD-10-CM hierarchy—and in fact could be worse. In 
addition to not being particularly user friendly (as ontology browsers do not seem to be designed 




study—the SNOMED browser only queries SNOMED concepts; the HPO browser provides 
equivalent SNOMED codes, but does not allow the user to browse any further into SNOMED. Neither 
browser includes explicit links to ICD-10-CM, which is critical for linkage with the EHR.  
 A better option is Athena (https://athena.ohdsi.org/search-terms/start), published and 
supported by the Observational Health Data Sciences and Informatics (OHDSI) program. Athena 
allows users to browse multiple vocabularies and ontologies at once—a search for “diabetes” brings 
up a great number of codes, including 644 ICD-10-CM codes and 989 SNOMED codes. With that 
wide of a net, however, this may actually be too much of a good thing. The code list is unordered, 
and quite tedious to wade through to find relevant codes.  
 A Goldilocks solution is to present investigators with a hybrid list of codes in the style of 
Athena, but with an order imposed to allow the user to easily navigate the list. Unlike codesets 
produced by the prior tools, this solution specifically leverages the affordances of the triplestore to 
order the list by both category and likely relevance. Figure 2 illustrates a possible format. 
 
Figure 2. A “hybrid” codeset for an investigator looking for a depression codeset. (The full code list 
has been abridged for readability.) Ontology-derived ICD-10-CM codes can be ordered by their 





This method of provisioning codesets to researchers has the following advantages over existing 
tools and methods: 
1. Ontology-derived codes are ordered by distance from the starting concept, meaning that 
codes that are too non-specific or less relevant will be more likely to sort to the bottom of 
the list. This addresses Athena’s problematic “bag of concepts”-style results, which 
overwhelms the user with a potentially huge volume of unordered codes. When a logical, 
graph-determined order is imposed as in the example above, the user can decide when to 
cut off their search. 
2. The extra table of codes not captured by the ontology query enables the inclusion of codes 
from other sources, such as PheKB, or even a Google search of the condition of interest. This 
manually curated list of “extra” codes addresses the issue of missing codes discussed in 
Chapter 6. The extra codes may also serve as a source of new corrections to submit to 
SNOMED, if they are missing due to an error in the ontology structure. In this way, this 
phenotyping methodology can directly contribute to the improvement of SNOMED over 
time. 
As the first table in Figure 2 can be auto-generated by a SPARQL query, the amount of effort 
needed on an informatician’s part to produce a phenotyping codeset “menu” in this format is 
reasonable. Presumably, the whole list could be auto-generated with a custom web application, the 
creation of which would be an interesting future project. Regardless, this hybrid codeset method is 
something I plan to incorporate in my future phenotyping efforts. 
7.3 A New Way to Share Phenotypes 
The open-source data processing pipeline created as part of this study enables the creation 




search of a use case that would require executing the pipeline at another institution, along with a 
shared set of SPARQL queries for distributed phenotyping and analytics. A successful inter-
institutional project using this infrastructure would not only attest to the utility of triplestores, 
ontologies, and FHIR in the context of data-driven clinical research, but also to clinical data (and 
computable phenotype) interoperability. 
Beyond computable phenotyping, using standard ontologies with clinical data can enable 
efficient linkage with other external datasets, including one or more of the datasets available on the 
web as Linked Open Data (LOD).1 Many of the datasets available as LOD are biomedical in nature, 
and could allow one to link EHR data with public data to discover, for example, gene-disease 
associations, genotype-phenotype associations, or drug-drug interactions. A use case requiring the 
inclusion of one or more such data sources in the project described above would be particularly 
compelling. 
7.4 Other Future Work: Going beyond Diagnosis Codes 
This study concentrated on diagnosis-related codes and concepts in ICD-10-CM, SNOMED, 
and HPO; however, the codesets used to match laboratory results, medications, observations, and 
procedures in computable phenotypes may have as much to gain from smarter use of ontologies as 
diagnoses. Procedures are a particularly interesting use case because, like ICD-10-CM, the Current 
Procedural Terminology (CPT) system used to code procedures is reimbursement-focused. A side-
effect of this focus is a non-intuitive hierarchy that makes it difficult to find the right codes; as was 
noted in Chapter 3, the range of CPT codes labelled as “surgery” include several procedures that 
may technically qualify as such—ear wax removal, for one—but would not generally be of interest 
to an investigator interested in patients who came in for surgery. Cross-walking CPT with SNOMED 
could allow procedures natively coded with CPT to be findable via a more intuitive, non-




7.5 Concluding Thoughts 
Though computable phenotypes are written, executed, and shared with great frequency 
today, computable phenotyping as a discipline has not yet reached the ideal of producing 
phenotypes that are shareable, data model agnostic, and semantically unambiguous. Some of these 
challenges may be addressed by exploring new solutions for storage and analysis of clinical data. 
Semantic web technologies are such an alternative, as ontologies can help to address semantic 
ambiguity introduced by reimbursement-focused codesets, and RDF and triplestores promote 
interoperability.  
As we get closer to realizing the computable phenotyping ideal, the impact on clinical, 
translational, and public health research will become even clearer. Indeed, using computable 
phenotypes to accurately identify patient cohorts and then widely and effectively sharing those 
phenotypes will enable a greater number of minds to answer challenging research questions and 











APPENDIX 1.1: ICD-10-CM CODES WITHIN THE DIABETES MELLITUS SUBGRAPH OF SNOMED, 
OTHER THAN CODES IN THE E08 THROUGH E13 RANGE. 
 
ICD-10-CM code Description 
E23.2 Diabetes insipidus 
E34.8 Other specified endocrine disorders 
E46 Unspecified protein-calorie malnutrition 
E66.9 Obesity, unspecified 
E84.9 Cystic fibrosis, unspecified 
E87.0 Hyperosmolality and hypernatremia 
E87.2 Acidosis 
E88.1 Lipodystrophy, not elsewhere classified 
E88.81 Metabolic syndrome 
F79 Unspecified intellectual disabilities 
G40.909 Epilepsy, unspecified, not intractable, without status epilepticus 
G52.9 Cranial nerve disorder, unspecified 
G53 Cranial nerve disorders in diseases classified elsewhere 
G58.7 Mononeuritis multiplex 
H21.1X9 Other vascular disorders of iris and ciliary body, unspecified eye 
H33.40 Traction detachment of retina, unspecified eye 
H34.9 Unspecified retinal vascular occlusion 
H35.041 Retinal micro-aneurysms, unspecified, right eye 
H35.042 Retinal micro-aneurysms, unspecified, left eye 
H40.9 Unspecified glaucoma 
H42 Glaucoma in diseases classified elsewhere 
H54.3 Unqualified visual loss, both eyes 
H90.5 Unspecified sensorineural hearing loss 
H91.90 Unspecified hearing loss, unspecified ear 
I70.90 Unspecified atherosclerosis 
K05.10 Chronic gingivitis, plaque induced 
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified 
K52.89 Other specified noninfective gastroenteritis and colitis 
K86.89 Other specified diseases of pancreas 
K86.9 Disease of pancreas, unspecified 
L68.0 Hirsutism 
L83 Acanthosis nigricans 
M54.12 Radiculopathy, cervical region 
M79.9 Soft tissue disorder, unspecified 
N17.2 Acute kidney failure with medullary necrosis 
N28.9 Disorder of kidney and ureter, unspecified 
N52.1 Erectile dysfunction due to diseases classified elsewhere 




O24.019 Pre-existing type 1 diabetes mellitus, in pregnancy, unspecified trimester 
O24.119 Pre-existing type 2 diabetes mellitus, in pregnancy, unspecified trimester 
O24.319 Unspecified pre-existing diabetes mellitus in pregnancy, unspecified 
trimester 
O24.32 Unspecified pre-existing diabetes mellitus in childbirth 
O24.33 Unspecified pre-existing diabetes mellitus in the puerperium 
O24.410 Gestational diabetes mellitus in pregnancy, diet controlled 
O24.414 Gestational diabetes mellitus in pregnancy, insulin controlled 
O24.419 Gestational diabetes mellitus in pregnancy, unspecified control 
O24.429 Gestational diabetes mellitus in childbirth, unspecified control 
O24.439 Gestational diabetes mellitus in the puerperium, unspecified control 
O24.919 Unspecified diabetes mellitus in pregnancy, unspecified trimeste 
O24.92 Unspecified diabetes mellitus in childbirth 
O24.93 Unspecified diabetes mellitus in the puerperium 
P70.1 Syndrome of infant of a diabetic mother 
P70.2 Neonatal diabetes mellitus 
P90 Convulsions of newborn 
Q04.3 Other reduction deformities of brain 
Q24.9 Congenital malformation of heart, unspecified 
Q45.0 Agenesis, aplasia and hypoplasia of pancreas 
Q87.0 Congenital malformation syndromes predominantly affecting facial 
appearance 
Q87.89 Other specified congenital malformation syndromes, not elsewhere 
classified 
R19.7 Diarrhea, unspecified 
R40.20 Unspecified coma 
R62.50 Unspecified lack of expected normal physiological development in 
childhood 
R80.1 Persistent proteinuria, unspecified 
R80.9 Proteinuria, unspecified 
S36.209? Unspecified injury of unspecified part of pancreas 
T38.0X5? Adverse effect of glucocorticoids and synthetic analogues 
T50.905? Adverse effect of unspecified drugs, medicaments and biological substances 
T86.99 Other complications of unspecified transplanted organ and tissue 
Z37.9 Outcome of delivery, unspecified 
Z79.4 Long term (current) use of insulin 






APPENDIX 2.1: SUMMARY OF STUDIES INVOLVING KEY-VALUE STORES 
 
*Reference numbers resolve to the Reference list at the end of Chapter 2. 
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provider 




















None SNOMED CT 
Lee 201347 Storing clinical 
data in a format 
more similar to 
its raw structure 
EHR  To keep data in a 
format closer to 
its raw structure; 









APPENDIX 2.2: SUMMARY OF STUDIES INVOLVING COLUMN STORES 
 
*Reference numbers resolve to the Reference list at the end of Chapter 2. 
 
Citation Purpose of 
system 
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data with EHRs to 
monitor elderly 
patients 
EHR, sensor & 
app data 
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EHR store for a 
large healthcare 
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EHR  High volume of 
data; 9M patients, 
growing 1 
TB/month 
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APPENDIX 2.3: SUMMARY OF STUDIES INVOLVING DOCUMENT STORES 
 
*Reference numbers resolve to the Reference list at the end of Chapter 2. 
 
Citation Purpose of 
system 
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EHR To allow direct 
querying on free-
text pathology 
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Lee 201347 Storing clinical 
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format close to its 
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APPENDIX 2.4: SUMMARY OF STUDIES INVOLVING TRIPLESTORES 
 
*Reference numbers resolve to the Reference list at the end of Chapter 2. 
 





























Bonner 201486 Assessing data 
quality in huge 
sets of clinical 
data (e.g., finding 
outliers) 
EHR Large size of the 
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potential drug-
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in patient data by 
linking to LOD 
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APPENDIX 2.5: SUMMARY OF STUDIES INVOLVING LABELLED PROPERTY GRAPHS 
 
*Reference numbers resolve to the Reference list at the end of Chapter 2. 
 
Citation Purpose of 
system 













concept model to 
query patient data 
EHR SNOMED CT is 
itself a directed, 
acyclic graph that 
does not 
translate well to 
the relational 
model 











and clinical data 
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better suited to 
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None None 
Kaur 201556 Constructing a 
“polyglot 
persistence” 
model where data 
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a format best 
suited to its raw 
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EHR To keep data in a 
format closer to 
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which is better 
suited to a graph 
None ICD-10 
Singh 201582 Migrating a 
relational 
database of EHR 
data to a graph 
EHR EHR data is 
highly 
interrelated and 
may be better 





APPENDIX 4.1: SPARQL QUERY REFERENCE 
 
Box A1. SPARQL queries to extract codes included in the SNOMED CT and HPO hierarchies for 
depression. (The PheKB codes were extracted directly from the phenotype documentation, and 
thus do not require a query.) 
 
#extract HPO-connected ICD-10-CM codes 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> 
PREFIX hpo: <http://purl.obolibrary.org/obo/> 
 




      ?hponode oboInOwl:hasDbXref ?xrefnode . 
      BIND(REPLACE(?xrefnode,"SNOMEDCT_US:","http://snomed.info/id/") as  
         ?xrefnode2) . 
      BIND(IRI(?xrefnode2) as ?snomednode) . 
      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      FILTER(?hponode = hpo:HP_0000716) #the hpo code for Depression 
      } 
 
#extract SNOMED-connected ICD-10-CM codes 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX oboInOwl: <http://www.geneontology.org/formats/oboInOwl#> 
PREFIX hpo: <http://purl.obolibrary.org/obo/> 
 
SELECT distinct ?snomednode ?icdnode ?icdsubnode 
WHERE { 
      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      FILTER(?snomednode = snomed:35489007) #the SNOMED code for Depression 
      } 
 
Box A2. Creating two graphs that contain the results of the PheKB and SNOMED/HPO Depression 
queries, respectively.  
 
#create graph for PheKB-identified patients 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX emdis: <http://emdiss.org/> 





INSERT {GRAPH <http://tracs.unc.edu/opioid_triplestore/emdissicdmatch>  
          {?patient a emdis:depresspt}} 
USING <http://tracs.unc.edu/opioid_triplestore/clinical/condition> 
WHERE { 
 ?cond fhir:Condition_subject / fhir:link ?patient . 
   ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a ?jpcode . 
         FILTER(?jpcode IN (fhiricd:F32.3, fhiricd:F33.3, fhiricd:F32.0,  
         fhiricd:F32.1, fhiricd:F32.2, fhiricd:F32.4, fhiricd:F32.5,  
         fhiricd:F32.9, fhiricd:F33.0, fhiricd:F33.1, fhiricd:F33.2,  
         fhiricd:F33.40, fhiricd:F33.41, fhiricd:F33.42, fhiricd:F33.9,  
         fhiricd:F32.89, fhiricd:F33.8, fhiricd:F43.21)) 
      } 
 
#create graph for SNOMED-identified patients 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 
PREFIX snomed: <http://snomed.info/id/> 
PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX emdis: <http://emdiss.org/> 
 
INSERT {GRAPH <http://tracs.unc.edu/opioid_triplestore/emdissontmatch>  




      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?snomednode = snomed:35489007)  
      } 
 
 
Box A3. SPARQL query to determine the list of patients who are present in the PheKB graph, but 
not the SNOMED/HPO graph. 
 
PREFIX emdis: <http://emdiss.org/> 
 
SELECT distinct ?s  
WHERE {  
      graph <http://tracs.unc.edu/opioid_triplestore/emdissicdmatch>  { ?s  
         a emdis:depresspt } . 
      FILTER NOT EXISTS {graph  
         <http://tracs.unc.edu/opioid_triplestore/emdissontmatch>  { ?s a  
         emdis:depresspt }} 
      } 
 
Box A4. Examining depression codes associated with the SNOMED/HPO-only patients. 
 
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> 
PREFIX skos: <http://www.w3.org/2004/02/skos/core#> 




PREFIX fhir: <http://hl7.org/fhir/> 
PREFIX emdis: <http://emdiss.org/> 
 
SELECT distinct ?patient ?icdnode ?icdsubnode 
FROM <http://tracs.unc.edu/opioid_triplestore/clinical/snomeddiss> 
FROM <http://tracs.unc.edu/opioid_triplestore/clinical/condition> 
WHERE {  
      ?snomednode skos:closeMatch ?icdnode . 
      ?snomedsubnode rdfs:subClassOf* ?snomednode . 
      ?snomedsubnode skos:closeMatch ?icdsubnode . 
      ?cond fhir:Condition_subject / fhir:link ?patient . 
      ?cond fhir:Condition_code / fhir:CodeableConcept_coding / a  
         ?anode . 
      FILTER(?anode = ?icdnode || ?anode = ?icdsubnode) . 
      FILTER(?snomednode = snomed:35489007) . 
      FILTER NOT EXISTS {graph  
         <http://tracs.unc.edu/opioid_triplestore/emdissicdmatch>  {  
         ?patient a emdis:depresspt }} 







APPENDIX 5.1 CORRESPONDENCE WITH IHTSDO REQUESTING A SNOMED ONTOLOGY CHANGE 
Email 1: From IHTSDO to Emily Pfaff (EP), after EP submitted a request ticket 
From: #################  
Sent: Monday, March 2, 2020 9:22 AM 
To: ################# 
Cc: #################; Pfaff, Emily <epfaff@email.unc.edu> 
Subject: Re: [#28869] Confluence account request from @ 3/1/2020 23:54:45  
Hi IHTSDO, 




Can you please describe the change you would like to see? Please include: 
e.g. 
Snomed SCTID: 371405004 
Snomed FSN: Disorder of eye proper (disorder) 
Description of change: please add a relationship to X 
 
Normally requests should go through your National Release Center (info below) but I understand 
that they are currently in the process of hiring for that position, so for this one could you please let 
me know what you would like to see changed. 
 
Inquiries of this nature should be submitted to the US National Library of Medicine (NLM) as they 
are responsible for the US extension of SNOMED CT and also for the submission of change requests 
for the International release of SNOMED CT. Change requests can be submitted to the NLM via their 
portal https://www.nlm.nih.gov/healthit/snomedct/ or for further information contact the 







Email 2: From EP to IHTSDO 
On Tue, 3 Mar at 6:19 PM , Pfaff, Emily <epfaff@email.unc.edu> wrote:  
Hello, 
  
Thanks so much for the reply! The change description is below: 
  
Snomed SCTID: 239792003  




Description of change: please add a relationship to Rheumatoid Arthritis (69896004)  
  
I am not sure whether this change will be seen as valid or not, so let me provide my rationale: In 
looking at the ICD10 hierarchy, Rheumatoid arthritis without rheumatoid factor (M06.0) is nested 
under “Other rheumatoid arthritis” (M06). However, in SNOMED, there is no relationship at all 
between seronegative rheumatoid arthritis and rheumatoid arthritis. 
  
Additionally, and I don’t know if this is the right thread to ask this on, I am very curious about the 
general process by which these kinds of decisions get made by the creators and maintainers of 
SNOMED CT. Is there a paper or any other source I could review to get more information on that? 
  
Thanks so much, 
Emily 
 
Email 3: From IHTSDO to EP, describing the change 
Hi Emily, 
Thank you for your email with the subject "Confluence account request from @ 3/1/2020 
23:54:45". 
 
First off, thank you so much for noting this and taking the time to let us know.   
I have remodeled the concept 239792003 |Seronegative rheumatoid arthritis (disorder)| and it 
now inherits under two supertypes: 
 69896004 |Rheumatoid arthritis (disorder)| 
 399112009 |Seronegative arthritis (disorder)| 
I have attached a screenshot of the new modeling.  This will change will be in the July 2020 
International Release of SNOMED. 
 
It is difficult to track down individual changes but generally, we review the literature, seek outside 
experts and follow our editorial guidelines 
(https://confluence.ihtsdotools.org/display/DOCEG/SNOMED+CT+Editorial+Guide).  There are 
also discussions about how we might be able to add annotations.   
 












Screenshot that accompanied email 3 
 
 
